{"meta":{"query_hash":"cf2946318e0f","filters":{"venue":"PharmacoEconomics & Outcomes News"},"cohort_total":104,"direct_labels_cover":1,"predictions_cover":104,"exported":104,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/cf2946318e0f","api":"https://metacan.xera.ac/api/v1/cohort?venue=PharmacoEconomics+%26+Outcomes+News"},"results":[{"id":"W4205687154","doi":"10.2165/00151234-200605110-00026","title":"Most of the new regulations stemming from Bill 102, the Transparent Drug System for Patients Act 2006, previously approved by the Ontario government in Canada, will soon come into effect,","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Quality of Life Research; Drug; Public administration; Business; Law; Public health; Political science; Medicine; Pharmacology","score_opus":0.05857380968842436,"score_gpt":0.3302997791268442,"score_spread":0.27172596943841987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205687154","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012734312,0.0036383371,0.004841939,0.6847676,0.01808947,0.0005427133,0.008492574,0.001090623,0.26580244],"genre_scores_gemma":[0.030868173,0.0023311586,0.0094263125,0.48870856,0.0035284008,0.0003264216,0.0038707464,0.00034129783,0.4605989],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9815213,0.00087108393,0.00077057554,0.00055946514,0.014089084,0.002188454],"domain_scores_gemma":[0.96625996,0.007734842,0.0025297038,0.0016685753,0.01684606,0.0049608657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00944445,0.00048257914,0.0008192835,0.001353653,0.0055207075,0.0062390976,0.0021348912,0.0136905145,0.017529042],"category_scores_gemma":[0.04589863,0.0009869772,0.001337894,0.0016807218,0.0036239938,0.002082599,0.0010901791,0.011641907,0.008011278],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050829796,0.00004985569,0.0023212486,0.00007326894,0.000014104995,0.00007482385,0.00022244672,0.00014436325,0.000672998,0.027612424,0.9575833,0.011180248],"study_design_scores_gemma":[0.0000778613,0.000045657154,0.024478516,0.00014385863,0.000031718333,0.000066794775,0.00029156765,0.0004024746,0.0006864427,0.003167949,0.9705081,0.000099131285],"about_ca_topic_score_codex":0.8284572,"about_ca_topic_score_gemma":0.94509834,"teacher_disagreement_score":0.9661404,"about_ca_system_score_codex":0.033859614,"about_ca_system_score_gemma":0.097920254,"threshold_uncertainty_score":0.34510612},"labels":[],"label_agreement":null},{"id":"W4205914124","doi":"10.1007/bf03275801","title":"STD screening, treatment in Canada needs improving","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.04010359644339216,"score_gpt":0.36062402336956006,"score_spread":0.3205204269261679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205914124","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009762987,0.008373761,0.00047496444,0.9499607,0.006219261,0.00006888704,0.0014249347,0.00032781687,0.023386635],"genre_scores_gemma":[0.16914172,0.036005937,0.009365263,0.682118,0.010157539,0.00012952792,0.0034114225,0.0002119643,0.0894586],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966394,0.00034237115,0.00024166294,0.00018899221,0.0013838502,0.0012036683],"domain_scores_gemma":[0.9660028,0.0026648873,0.0009951971,0.00037430206,0.01240876,0.01755402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003777498,0.0004136064,0.00061558007,0.0013732067,0.0048569147,0.005715904,0.0017205185,0.008868341,0.030666357],"category_scores_gemma":[0.016421407,0.0004008416,0.0011051286,0.0020162535,0.0020022076,0.0021795998,0.0013580195,0.0056519406,0.0022012838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021597554,0.00020977973,0.024398414,0.0006364556,0.000060599883,0.00038058017,0.0003669963,0.00040116892,0.0005412873,0.005048012,0.84733474,0.12040605],"study_design_scores_gemma":[0.00035697172,0.00017597454,0.15768105,0.0015546769,0.00023190037,0.0003902632,0.004169848,0.0012293541,0.000444037,0.003571766,0.8300726,0.00012157195],"about_ca_topic_score_codex":0.962573,"about_ca_topic_score_gemma":0.98786724,"teacher_disagreement_score":0.03742701,"about_ca_system_score_codex":0.03677395,"about_ca_system_score_gemma":0.2599103,"threshold_uncertainty_score":0.26681495},"labels":[],"label_agreement":null},{"id":"W4205978106","doi":"10.1007/bf03275954","title":"Nearly one-quarter market share for hep C prescriptions held by Roche's PEG IFN-α-2a","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medical prescription; Quality of Life Research; Medicine; Pharmacology; History; Public health","score_opus":0.0600780015680309,"score_gpt":0.44911276695689833,"score_spread":0.38903476538886744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205978106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5721126,0.034211148,0.0027821206,0.08325873,0.006110407,0.00015829997,0.025990369,0.0017268042,0.27364942],"genre_scores_gemma":[0.8244064,0.010091247,0.00064117776,0.014491794,0.0044013388,0.000044571545,0.009023295,0.00010620025,0.13679397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967873,0.000034239576,0.000011636127,0.0000384431,0.00016671489,0.00007019692],"domain_scores_gemma":[0.99923325,0.00027423448,0.0001675657,0.000020004185,0.00009205857,0.00021287838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040047723,0.00033075034,0.00033165058,0.0006676637,0.00031225837,0.00091667386,0.0002361151,0.0009586845,0.023259126],"category_scores_gemma":[0.0011477481,0.00011691354,0.0005897032,0.0005624997,0.00020600583,0.0005551229,0.00034668413,0.0008296872,0.005022868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031330371,0.00034232181,0.06802215,0.000354346,0.0002560203,0.0020266285,0.00020217262,0.00048382295,0.029540772,0.0040900367,0.44136018,0.45018846],"study_design_scores_gemma":[0.00071848027,0.0014899969,0.34829924,0.0002510359,0.00037416763,0.0063120383,0.0010540796,0.0034291325,0.020101862,0.0011710991,0.61673266,0.000066240114],"about_ca_topic_score_codex":0.0033748606,"about_ca_topic_score_gemma":0.0038351642,"teacher_disagreement_score":0.023259126,"about_ca_system_score_codex":0.00065165316,"about_ca_system_score_gemma":0.00062679517,"threshold_uncertainty_score":0.07780957},"labels":[],"label_agreement":null},{"id":"W4206588241","doi":"10.1007/bf03269529","title":"Canadian recommendations on varicella zoster virus vaccine","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Varicella zoster virus; Chickenpox Vaccine; Quality of Life Research; Medicine; Varicella vaccine; Virus; Public health; Immunization; Immunology; Antibody","score_opus":0.027398837020450605,"score_gpt":0.3591745588026716,"score_spread":0.331775721782221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206588241","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000770033,0.028314618,0.0004153167,0.8192326,0.043410983,0.00018099531,0.004201466,0.00016935355,0.10330476],"genre_scores_gemma":[0.017152032,0.060073692,0.0055490835,0.7667543,0.022112545,0.00036718728,0.005337657,0.0001588591,0.122494616],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98547006,0.0017539215,0.0013579933,0.00048787627,0.008319404,0.0026107198],"domain_scores_gemma":[0.9667076,0.003463438,0.0010781675,0.00040189552,0.02295927,0.005389622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006818434,0.0010606187,0.0011691143,0.004357416,0.004444964,0.004833952,0.003437047,0.017213568,0.038150206],"category_scores_gemma":[0.03020084,0.00077243516,0.0024218212,0.0045199986,0.0022449018,0.0022750576,0.0017426428,0.014571523,0.0057734572],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030056626,0.000016526077,0.00029631067,0.00015939078,0.000016007758,0.000067832494,0.000042051284,0.00007170924,0.000045595247,0.0021707353,0.98476464,0.012319139],"study_design_scores_gemma":[0.00013032183,0.000014106296,0.0031637868,0.0009244137,0.00007716329,0.00008649382,0.00013031611,0.000073995776,0.00007337451,0.0012044694,0.9940836,0.0000379103],"about_ca_topic_score_codex":0.91789454,"about_ca_topic_score_gemma":0.947826,"teacher_disagreement_score":0.08210546,"about_ca_system_score_codex":0.03034268,"about_ca_system_score_gemma":0.15731277,"threshold_uncertainty_score":0.22015262},"labels":[],"label_agreement":null},{"id":"W4206766375","doi":"10.2165/00151234-200404670-00020","title":"Benzodiazepines used for long periods among Canadian elderly","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Quality of Life Research; Public health; Medicine; Psychology; Pharmacology; Nursing","score_opus":0.04899817707140249,"score_gpt":0.4331009132495601,"score_spread":0.38410273617815766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206766375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744862,0.0039775753,0.00006983698,0.004117648,0.00011685069,0.000051094947,0.00347741,0.000016625969,0.013686693],"genre_scores_gemma":[0.9898352,0.003531096,0.00014974925,0.0017940314,0.000080121834,0.000013683928,0.0008923297,0.000007314176,0.0036964847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930954,0.000028292141,0.00005225,0.0000518336,0.0002949453,0.0002630864],"domain_scores_gemma":[0.99792576,0.00009110597,0.0005080815,0.000023772307,0.0009307244,0.00052049797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032606843,0.00028504548,0.00033331278,0.0013517245,0.0028348174,0.0011218709,0.00068113476,0.00078650605,0.0031788326],"category_scores_gemma":[0.0020234403,0.00030175978,0.0005381618,0.0030671544,0.00048441463,0.0005494001,0.00063692866,0.0011954039,0.00029928747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020759371,0.000106101834,0.97124344,0.00015252546,0.00005420661,0.0009459514,0.0018598079,0.00006171219,0.00025163102,0.00019580587,0.00708267,0.017838635],"study_design_scores_gemma":[0.000021284703,0.0000495183,0.98939717,0.00010583446,0.000070164235,0.0005844227,0.005010361,0.00010252077,0.00007611217,0.000025918738,0.0045322524,0.000024381816],"about_ca_topic_score_codex":0.9894357,"about_ca_topic_score_gemma":0.9956435,"teacher_disagreement_score":0.020728555,"about_ca_system_score_codex":0.020728555,"about_ca_system_score_gemma":0.024062676,"threshold_uncertainty_score":0.15039694},"labels":[],"label_agreement":null},{"id":"W4210414282","doi":"10.1007/s40274-021-08159-x","title":"Active TB screening may be cost saving in high-incidence Inuit communities in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Incidence (geometry); Public health; Environmental health; Medicine; Demography; Sociology; Mathematics; Nursing","score_opus":0.05181062410397016,"score_gpt":0.35541847498461887,"score_spread":0.30360785088064873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210414282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6728988,0.014873456,0.0008267825,0.24319299,0.0020164873,0.00014119183,0.004691674,0.00014854946,0.061210003],"genre_scores_gemma":[0.9740918,0.0056411675,0.0005348111,0.012298984,0.0003608156,0.000020726202,0.00068273075,0.00003263707,0.006336396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922097,0.000091914626,0.000034935936,0.00004661464,0.00017263851,0.00043298746],"domain_scores_gemma":[0.99689215,0.00033132112,0.00035661994,0.000025290998,0.00089166174,0.0015030091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040640106,0.0001860254,0.00027025412,0.00050071423,0.0019761652,0.0024752463,0.00083844626,0.0011069402,0.009259124],"category_scores_gemma":[0.0056611644,0.00020117559,0.00046513148,0.0011541486,0.000663054,0.0006343325,0.00061539974,0.0021110051,0.00023675033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069344183,0.00059511856,0.6954149,0.0006034658,0.0002670571,0.0014072021,0.0020091226,0.0012830518,0.00070344005,0.004821104,0.14093734,0.15126465],"study_design_scores_gemma":[0.0002628375,0.0002207523,0.94047195,0.001481957,0.0005072819,0.000595579,0.010757357,0.0034653866,0.00042544183,0.002627126,0.03909293,0.000091434515],"about_ca_topic_score_codex":0.9847706,"about_ca_topic_score_gemma":0.99460125,"teacher_disagreement_score":0.023010856,"about_ca_system_score_codex":0.023010856,"about_ca_system_score_gemma":0.048677634,"threshold_uncertainty_score":0.16695625},"labels":[],"label_agreement":null},{"id":"W4210434457","doi":"10.1007/bf03275923","title":"US seniors retaliate against GSK over reduced drug supplies in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Drug; Environmental health; Business; Medicine; Pharmacology; Nursing","score_opus":0.02673352025819704,"score_gpt":0.2930338517553045,"score_spread":0.26630033149710747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210434457","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5659233,0.0034500374,0.00024313245,0.34434122,0.001099497,0.000155224,0.0014928806,0.00012116824,0.08317359],"genre_scores_gemma":[0.8809975,0.0018372176,0.0001374748,0.055652577,0.00047230086,0.000020210924,0.00032704143,0.000040323728,0.060515337],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949602,0.0002295272,0.00012959595,0.00018472513,0.0018710762,0.002624869],"domain_scores_gemma":[0.97956103,0.0025283406,0.0032027233,0.0002609503,0.005025324,0.009421665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430285,0.0002206499,0.00045188062,0.0014327407,0.008298345,0.0046965685,0.001454398,0.0073148375,0.008077267],"category_scores_gemma":[0.015249924,0.00047406415,0.00056982884,0.0016833673,0.0024248876,0.00096492626,0.0017829855,0.0066279355,0.0006633018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010423581,0.0004658172,0.28493512,0.00017017098,0.00017372286,0.002375937,0.006463757,0.0014048885,0.0007800996,0.015628794,0.6285164,0.058043033],"study_design_scores_gemma":[0.0006545088,0.00034421415,0.6992579,0.0003635702,0.00037142436,0.001091437,0.02908358,0.0057278303,0.0014609207,0.0033985404,0.2580034,0.00024251586],"about_ca_topic_score_codex":0.9865568,"about_ca_topic_score_gemma":0.9961175,"teacher_disagreement_score":0.06550599,"about_ca_system_score_codex":0.06550599,"about_ca_system_score_gemma":0.102610365,"threshold_uncertainty_score":0.47528142},"labels":[],"label_agreement":null},{"id":"W4210470270","doi":"10.1007/bf03267359","title":"Canadian normative SF-36 data published","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Law, logistics, and international trade","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Normative; Political science; Public health; Law; Medicine","score_opus":0.05088517960913186,"score_gpt":0.3059408706275935,"score_spread":0.25505569101846165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210470270","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036825477,0.0023764484,0.0006058877,0.0025850725,0.00069983886,0.00053696387,0.8927713,0.00022433884,0.096517615],"genre_scores_gemma":[0.040128864,0.0064670118,0.0038595342,0.0016689231,0.00022399261,0.002060233,0.8666319,0.00039278125,0.07856669],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9879362,0.00067208026,0.0012111609,0.00059529784,0.008110405,0.001474823],"domain_scores_gemma":[0.9486039,0.002353393,0.0009188029,0.0012844374,0.045406565,0.0014329371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004984703,0.0013747129,0.0015852179,0.016962666,0.00476839,0.0045437473,0.0025639615,0.0011158808,0.10038085],"category_scores_gemma":[0.04206107,0.0007922782,0.002070869,0.03032233,0.0011463921,0.0014142091,0.0018102687,0.0024363014,0.032934424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030066585,0.00005232822,0.015759844,0.0008094222,0.00008046538,0.00010195912,0.00028287698,0.0004351575,0.00007920376,0.0058291103,0.93495625,0.041312777],"study_design_scores_gemma":[0.00018372224,0.000050416424,0.17102359,0.0017862885,0.00016795094,0.00018857785,0.0009880367,0.00026550808,0.000291096,0.0026426346,0.8222612,0.00015092688],"about_ca_topic_score_codex":0.9862177,"about_ca_topic_score_gemma":0.98777056,"teacher_disagreement_score":0.10038085,"about_ca_system_score_codex":0.046667032,"about_ca_system_score_gemma":0.124809526,"threshold_uncertainty_score":0.33859462},"labels":[],"label_agreement":null},{"id":"W4212981773","doi":"10.2165/00151234-201106410-00034","title":"Healthcare spending to reach > $200 billion in 2011 in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Health economics; Health spending; Public health; Economics; Business; Medicine; Economic growth; Health insurance; Nursing","score_opus":0.11026723973413086,"score_gpt":0.3291838321007124,"score_spread":0.21891659236658154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212981773","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2762994,0.02572666,0.00063307554,0.3942579,0.0053304182,0.00017446009,0.16381688,0.00048052566,0.1332807],"genre_scores_gemma":[0.79291725,0.015170875,0.00084218365,0.026792174,0.00087984523,0.00010584742,0.029195292,0.00017588933,0.13392067],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9971551,0.00009495103,0.00010149212,0.00015074246,0.001320399,0.0011773392],"domain_scores_gemma":[0.9945938,0.0001700651,0.00038157115,0.00003736077,0.0020777443,0.002739475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010032892,0.00046645064,0.0006742689,0.0019976213,0.0036795647,0.0050705094,0.0011254069,0.0025688831,0.008685058],"category_scores_gemma":[0.004886943,0.00045173563,0.0010338554,0.004016709,0.0009178328,0.0011927378,0.00142698,0.004007346,0.0009286427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004278872,0.00012286303,0.10193707,0.00043099522,0.00022288862,0.00046405627,0.00060627726,0.002679853,0.00019964293,0.016374657,0.83637315,0.04016058],"study_design_scores_gemma":[0.00020280585,0.000067255576,0.5700738,0.00081023155,0.00026308268,0.00033417493,0.0046371156,0.004616325,0.0005066717,0.0021981853,0.41615313,0.00013719378],"about_ca_topic_score_codex":0.99795663,"about_ca_topic_score_gemma":0.99913895,"teacher_disagreement_score":0.14099418,"about_ca_system_score_codex":0.14099418,"about_ca_system_score_gemma":0.23070994,"threshold_uncertainty_score":0.996325},"labels":[],"label_agreement":null},{"id":"W4213052584","doi":"10.1007/bf03278651","title":"Best case needed to see oseltamivir value for 'flu in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oseltamivir; Quality of Life Research; Value (mathematics); Medicine; Public health; Coronavirus disease 2019 (COVID-19); Mathematics; Statistics; Internal medicine","score_opus":0.04731400848501163,"score_gpt":0.34058062178501364,"score_spread":0.29326661330000203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213052584","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015159468,0.012572957,0.00018253757,0.9187404,0.010356602,0.0001503938,0.0030228712,0.00010611923,0.039708633],"genre_scores_gemma":[0.20418152,0.015185263,0.0025347164,0.7206891,0.008327494,0.00017846991,0.0018667426,0.00009153715,0.04694518],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99582654,0.00074389414,0.0002807932,0.0001980796,0.0014936776,0.0014570603],"domain_scores_gemma":[0.9726519,0.0048418622,0.00078528584,0.00031710145,0.009813429,0.011590388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038774179,0.00040306768,0.0009040896,0.0011542306,0.0041647647,0.005236506,0.0016495538,0.011966537,0.024479311],"category_scores_gemma":[0.017629312,0.00034151442,0.0011920586,0.001280076,0.0017479265,0.0016615695,0.0011722523,0.0055226954,0.0011101993],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001355934,0.00017533716,0.021355081,0.0007648333,0.00022710663,0.0016623345,0.00034251026,0.0007776723,0.00057434937,0.010237353,0.9073656,0.05516179],"study_design_scores_gemma":[0.002838202,0.00046458296,0.09640941,0.0034633502,0.00079153816,0.0007310868,0.003997244,0.001434905,0.0011385656,0.011636789,0.876777,0.00031732392],"about_ca_topic_score_codex":0.9538203,"about_ca_topic_score_gemma":0.9799744,"teacher_disagreement_score":0.04617971,"about_ca_system_score_codex":0.032141592,"about_ca_system_score_gemma":0.17754464,"threshold_uncertainty_score":0.23320472},"labels":[],"label_agreement":null},{"id":"W4213146317","doi":"10.1007/bf03279452","title":"Effect of H2-antagonist Rx-to-OTC switch in the US, UK and Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Public health","score_opus":0.011070616997440103,"score_gpt":0.3012965126590904,"score_spread":0.2902258956616503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213146317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9489599,0.00618942,0.000055954246,0.013251478,0.0003468083,0.00009346574,0.0043456573,0.000045542787,0.026711877],"genre_scores_gemma":[0.97987765,0.0026420169,0.000081224076,0.002592207,0.00008698919,0.00001319916,0.0012313001,0.000021403093,0.013453986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988803,0.00009522749,0.000043643086,0.000079671394,0.00031599513,0.0005850261],"domain_scores_gemma":[0.9966954,0.0003017959,0.00020446957,0.000038021397,0.0013767339,0.0013835427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000627154,0.00019822805,0.00056600105,0.0005034174,0.0017883189,0.0013715514,0.00089882355,0.0011675956,0.007670798],"category_scores_gemma":[0.003201133,0.00018007847,0.0005691357,0.0012754112,0.00082759565,0.00043414807,0.0005295065,0.0011356139,0.00044263198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07717562,0.002399999,0.5403326,0.0007357592,0.0009960458,0.002705614,0.0032776422,0.0049585993,0.0047985218,0.004372247,0.13663699,0.22161025],"study_design_scores_gemma":[0.0016451747,0.0018865259,0.95433605,0.00015464613,0.0004096068,0.00031220197,0.005032005,0.0009246984,0.0010324221,0.00019493233,0.033972614,0.000099268545],"about_ca_topic_score_codex":0.9915868,"about_ca_topic_score_gemma":0.9958319,"teacher_disagreement_score":0.03564154,"about_ca_system_score_codex":0.03564154,"about_ca_system_score_gemma":0.04014968,"threshold_uncertainty_score":0.25859863},"labels":[],"label_agreement":null},{"id":"W4229933154","doi":"10.2165/00151234-200705310-00009","title":"High intensity use of proton pump inhibitors (PPIs) increased between 1997 and 2004 in Canada,","year":2007,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Intensity (physics); Medicine; Public health; Optics; Physics","score_opus":0.02376855002883469,"score_gpt":0.3031655579418374,"score_spread":0.2793970079130027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229933154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9116043,0.012034937,0.00040566444,0.017529242,0.00043749734,0.00013254404,0.042435277,0.00013618893,0.015284394],"genre_scores_gemma":[0.9745111,0.004227074,0.0007578697,0.0038104318,0.00007947174,0.00004528786,0.0074256817,0.000024363515,0.009118661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983468,0.00006690805,0.00014437303,0.0001799303,0.00076559145,0.0004963479],"domain_scores_gemma":[0.99419594,0.0002148903,0.0013166239,0.00006749756,0.00288569,0.0013194092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005387289,0.00035190445,0.00047376557,0.001831571,0.0019411129,0.0020644343,0.0014132882,0.0014335847,0.0032253468],"category_scores_gemma":[0.004411581,0.0004959461,0.0009746504,0.0062908735,0.00065288803,0.0007537801,0.00086328824,0.0016186739,0.00033028465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012654933,0.000050788956,0.9787981,0.00018238074,0.00015138493,0.0002501594,0.00040834365,0.00017280426,0.00022793267,0.00020114028,0.00897841,0.010451943],"study_design_scores_gemma":[0.0000079907895,0.000012689403,0.995239,0.000059310376,0.000040080304,0.00010782732,0.0006592264,0.00014427239,0.00007032831,0.00001502623,0.0036356791,0.000008616529],"about_ca_topic_score_codex":0.99705243,"about_ca_topic_score_gemma":0.99838436,"teacher_disagreement_score":0.04619711,"about_ca_system_score_codex":0.04619711,"about_ca_system_score_gemma":0.074343316,"threshold_uncertainty_score":0.33518505},"labels":[],"label_agreement":null},{"id":"W4230020078","doi":"10.1007/bf03280012","title":"Universal healthcare sustainable in Canada?","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Public health; Health economics; Health administration; Business; Economics; Medicine; Nursing; Economic growth","score_opus":0.03102327070289286,"score_gpt":0.3012074803041892,"score_spread":0.27018420960129635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230020078","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02970116,0.00461412,0.00035604287,0.9006616,0.0023654965,0.00004730774,0.0010040952,0.00006787108,0.06118236],"genre_scores_gemma":[0.5257018,0.008063394,0.0021542024,0.37047693,0.0013280754,0.00013320406,0.0010115752,0.00020339202,0.090927504],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98947793,0.0007148884,0.00026253393,0.0005753964,0.0025112983,0.0064579924],"domain_scores_gemma":[0.9701638,0.0017741331,0.00084833417,0.00063026435,0.0066136294,0.019969903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057351636,0.00043672556,0.0007185654,0.0017183897,0.014319635,0.012920198,0.0029381714,0.01115387,0.030182356],"category_scores_gemma":[0.02086864,0.0007174736,0.001131648,0.0031678984,0.0073639536,0.006006966,0.006914881,0.014125859,0.0009203329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017152585,0.00015495316,0.024253089,0.00024223511,0.000089193585,0.00074682006,0.0034696017,0.0006481374,0.00029319426,0.40453276,0.5029121,0.062486473],"study_design_scores_gemma":[0.00018367246,0.000067126784,0.07745472,0.00086825824,0.000111510126,0.0003451882,0.018032767,0.0009665063,0.00046180005,0.063769266,0.83752847,0.00021066867],"about_ca_topic_score_codex":0.9898498,"about_ca_topic_score_gemma":0.9950754,"teacher_disagreement_score":0.88082695,"about_ca_system_score_codex":0.119173035,"about_ca_system_score_gemma":0.46754622,"threshold_uncertainty_score":0.8646649},"labels":[],"label_agreement":null},{"id":"W4230031586","doi":"10.1007/bf03267249","title":"Propentofylline worth it in Canada's AD population","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.01827595898962494,"score_gpt":0.3298364210698375,"score_spread":0.3115604620802126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230031586","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34615347,0.054747995,0.0003189352,0.47744188,0.0047993413,0.00007334565,0.0020134116,0.000098336954,0.11435332],"genre_scores_gemma":[0.8766321,0.031894106,0.00073718606,0.063469164,0.0034414495,0.000014522833,0.0007257813,0.00005112349,0.023034606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996978,0.000022778435,0.000018791214,0.000021704594,0.0001297634,0.00010912335],"domain_scores_gemma":[0.998621,0.00013701618,0.000082382954,0.00001988444,0.0004430962,0.00069664523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003530094,0.00012528566,0.00029574556,0.0004648037,0.0015940602,0.001262015,0.00032173545,0.0012772433,0.0049041905],"category_scores_gemma":[0.0020509113,0.0000724677,0.00020940657,0.0008032049,0.0006794785,0.00048405532,0.00021105162,0.0022912289,0.0003633527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002678729,0.00046300594,0.124081686,0.00036796762,0.00007398239,0.005211048,0.00078132964,0.00017758778,0.001586377,0.0035903326,0.37683904,0.48414892],"study_design_scores_gemma":[0.0009829517,0.001349238,0.46304545,0.001201322,0.00056772085,0.00844804,0.0063244025,0.0006402474,0.001333374,0.0038991487,0.51209867,0.00010944676],"about_ca_topic_score_codex":0.7163455,"about_ca_topic_score_gemma":0.921302,"teacher_disagreement_score":0.2836545,"about_ca_system_score_codex":0.0071113887,"about_ca_system_score_gemma":0.016405648,"threshold_uncertainty_score":0.57065},"labels":[],"label_agreement":null},{"id":"W4230081928","doi":"10.1007/bf03280326","title":"Sumatriptan nearly always cost saving for Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Sumatriptan; Business; Economics; Public health; Medicine","score_opus":0.02529442409879043,"score_gpt":0.32867776140831495,"score_spread":0.3033833373095245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230081928","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049949378,0.036774803,0.00054287416,0.5984967,0.009224733,0.00007501876,0.010680604,0.00041147697,0.29384452],"genre_scores_gemma":[0.43420428,0.08070792,0.002940344,0.15831245,0.0074699847,0.000053194282,0.007806416,0.00033708426,0.30816832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909675,0.00004927525,0.00003096899,0.00004353667,0.0005871249,0.00019225775],"domain_scores_gemma":[0.9971306,0.0002636664,0.00018370125,0.000057723788,0.0013963071,0.0009681151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036404427,0.00020925008,0.00026950202,0.00095784856,0.0013768977,0.0016745212,0.00042216407,0.00112555,0.039267924],"category_scores_gemma":[0.0044940365,0.00016599114,0.00047236859,0.0014403742,0.00051662966,0.00055267115,0.0005207545,0.0022718885,0.0019619921],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040791297,0.000046047895,0.009915537,0.00020495469,0.000088991204,0.0003588388,0.000060943188,0.00027489598,0.00084980926,0.0047287783,0.81615597,0.16690731],"study_design_scores_gemma":[0.00028224284,0.00013148262,0.055834014,0.00059220416,0.00023973042,0.0006818266,0.00057556346,0.0004299493,0.0010821853,0.0021910185,0.93791115,0.00004866941],"about_ca_topic_score_codex":0.86352223,"about_ca_topic_score_gemma":0.93571174,"teacher_disagreement_score":0.13647777,"about_ca_system_score_codex":0.013960652,"about_ca_system_score_gemma":0.047214996,"threshold_uncertainty_score":0.27456295},"labels":[],"label_agreement":null},{"id":"W4230202677","doi":"10.1007/s40274-014-1349-2","title":"Guanfacine's stimulating results in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Animal Nutrition and Physiology","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guanfacine; Quality of Life Research; Economics; Medicine; Public health; Anesthesia; Clonidine","score_opus":0.02343419157195818,"score_gpt":0.27642799691090236,"score_spread":0.25299380533894417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230202677","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010016248,0.03361147,0.00021848264,0.82522744,0.054190587,0.00010064046,0.0022807692,0.00025109024,0.07410322],"genre_scores_gemma":[0.14950323,0.06538628,0.0013369581,0.40771353,0.041196227,0.00011535142,0.0031146444,0.00028314852,0.33135056],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99698395,0.00018451607,0.00007813603,0.00012881593,0.0017752422,0.00084932457],"domain_scores_gemma":[0.99022394,0.0005938977,0.0002839373,0.00012863571,0.0022316314,0.0065379366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027631144,0.0006394336,0.00046338208,0.00084662455,0.0020362642,0.0036531896,0.0010541385,0.007914114,0.01946916],"category_scores_gemma":[0.0055150245,0.0002454556,0.0007733738,0.001149282,0.0017900936,0.00071110704,0.0013279149,0.0057597854,0.002166907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002877541,0.00010088382,0.0013864536,0.00010803764,0.000024206574,0.00050594204,0.00004101706,0.0000975393,0.00035397967,0.0017014043,0.96483517,0.03055758],"study_design_scores_gemma":[0.0004542537,0.00020776693,0.019736167,0.00022283166,0.00004037675,0.00025432184,0.00031885845,0.00017113372,0.00048856414,0.0006039429,0.97746587,0.000035919194],"about_ca_topic_score_codex":0.7009103,"about_ca_topic_score_gemma":0.8508496,"teacher_disagreement_score":0.29908973,"about_ca_system_score_codex":0.015006738,"about_ca_system_score_gemma":0.0620645,"threshold_uncertainty_score":0.6017022},"labels":[],"label_agreement":null},{"id":"W4230377058","doi":"10.1007/bf03275770","title":"Paracetamol vs NSAID prescribing among the elderly in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Health economics; Public health; Nursing","score_opus":0.013351717169690816,"score_gpt":0.2757582234878619,"score_spread":0.2624065063181711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230377058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625415,0.010650679,0.00003655925,0.014893375,0.00022068244,0.000024043506,0.0025164096,0.000010242208,0.009106586],"genre_scores_gemma":[0.9894359,0.0057704635,0.00007619911,0.0021970242,0.0001544393,0.0000056249737,0.0004955362,0.0000059086324,0.0018588705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995883,0.000037081994,0.00003254634,0.00003080486,0.00016529248,0.00014604995],"domain_scores_gemma":[0.9971686,0.0003165693,0.0004477187,0.000025663974,0.0009101823,0.0011312806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034009054,0.00011301108,0.00038945235,0.0004734538,0.0012663377,0.0010849254,0.0004567537,0.0008369276,0.0026975626],"category_scores_gemma":[0.0035155653,0.00016748704,0.00039322753,0.0024182345,0.00032088358,0.00037255656,0.00027318174,0.0009467865,0.0001394982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002368906,0.00022524895,0.94180256,0.00021133016,0.00019105112,0.00050213246,0.0007127773,0.00027900928,0.00029153773,0.00037698314,0.015233507,0.037805047],"study_design_scores_gemma":[0.0001598731,0.000121886995,0.99208814,0.00014681909,0.00017744386,0.00016437094,0.0020973498,0.00048029423,0.00009545394,0.00008070911,0.0043671792,0.000020569492],"about_ca_topic_score_codex":0.98046035,"about_ca_topic_score_gemma":0.99397534,"teacher_disagreement_score":0.019539654,"about_ca_system_score_codex":0.01571505,"about_ca_system_score_gemma":0.02020074,"threshold_uncertainty_score":0.11402118},"labels":[],"label_agreement":null},{"id":"W4230555985","doi":"10.2165/00151234-200605140-00024","title":"Isotretinoin use inappropriate in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Isotretinoin; Quality of Life Research; Medicine; Dermatology; Public health; Nursing","score_opus":0.01338503712542532,"score_gpt":0.2821876621866829,"score_spread":0.26880262506125757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230555985","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8753282,0.008886991,0.00021565362,0.053036805,0.00062271574,0.00013750973,0.011604305,0.000075399286,0.05009239],"genre_scores_gemma":[0.9816206,0.004423795,0.0002016247,0.007398962,0.00015245014,0.000019591915,0.0015204867,0.000030902553,0.0046314155],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836296,0.0001049467,0.00014921854,0.000119645054,0.0007069612,0.00055626134],"domain_scores_gemma":[0.9923505,0.00065661577,0.001374547,0.00008347077,0.0032539405,0.0022809575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033678964,0.00020600074,0.00043740426,0.0013733945,0.0033608275,0.001747938,0.0011864603,0.0014586943,0.0060210126],"category_scores_gemma":[0.004379633,0.00031732811,0.00056749146,0.0046873917,0.0006925229,0.00045094726,0.0006202417,0.0024733406,0.00026904556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034470196,0.00018408825,0.9176048,0.00022906263,0.0001248548,0.0036768753,0.0013769584,0.0004047909,0.00045555804,0.0017735204,0.04218372,0.03164118],"study_design_scores_gemma":[0.00008939815,0.000069872054,0.9769795,0.00021789367,0.00012842922,0.0014543232,0.00438485,0.0010277145,0.00019675445,0.0002983305,0.01509343,0.000059417158],"about_ca_topic_score_codex":0.99544924,"about_ca_topic_score_gemma":0.9977895,"teacher_disagreement_score":0.031763498,"about_ca_system_score_codex":0.031763498,"about_ca_system_score_gemma":0.08821819,"threshold_uncertainty_score":0.23046136},"labels":[],"label_agreement":null},{"id":"W4230561190","doi":"10.2165/00151234-201006090-00003","title":"Grade A NACI recommendation for rotavirus vaccine in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Rotavirus vaccine; Rotavirus; Virology; Medicine; Public health; Virus; Nursing","score_opus":0.03283751322459917,"score_gpt":0.3880215328744271,"score_spread":0.35518401964982793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230561190","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016755147,0.030320859,0.0008285317,0.7991058,0.046044126,0.0015820022,0.022747938,0.00029381659,0.08232178],"genre_scores_gemma":[0.13565455,0.029651757,0.0056207725,0.74609864,0.027204981,0.0010843123,0.014688561,0.00017987104,0.03981652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908896,0.0014302696,0.0014162493,0.00047822762,0.0046857083,0.0010998988],"domain_scores_gemma":[0.93809736,0.010590399,0.006081804,0.00079206435,0.03500374,0.009434661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065273778,0.0006772323,0.0015613172,0.003090591,0.0024573281,0.0028593906,0.0030460635,0.012685513,0.0151828155],"category_scores_gemma":[0.069982715,0.0007020185,0.0024913622,0.0028225149,0.0010948563,0.00081355334,0.00089460966,0.007187327,0.0024045566],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049367006,0.000039974042,0.012637338,0.0012853956,0.00032073964,0.00014841596,0.000057206355,0.00017667828,0.00017976221,0.00045047054,0.9616549,0.022555465],"study_design_scores_gemma":[0.003712203,0.00039759424,0.156954,0.011574604,0.003543315,0.00064340496,0.00063051854,0.0016543424,0.0008307061,0.0018651661,0.8179775,0.00021657764],"about_ca_topic_score_codex":0.7814216,"about_ca_topic_score_gemma":0.8942872,"teacher_disagreement_score":0.2185784,"about_ca_system_score_codex":0.01922491,"about_ca_system_score_gemma":0.07157193,"threshold_uncertainty_score":0.43973124},"labels":[],"label_agreement":null},{"id":"W4230928897","doi":"10.1007/s40274-013-0659-0","title":"Self-injectable SC abatacept available in Canada for RA","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Quality of Life Research; Medicine; Public health; Internal medicine; Nursing","score_opus":0.018339566568218123,"score_gpt":0.28105739096763044,"score_spread":0.2627178243994123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230928897","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20326121,0.08030764,0.00077179464,0.52290696,0.011869483,0.000251253,0.016134178,0.00050302595,0.16399449],"genre_scores_gemma":[0.71865743,0.06214648,0.0017949846,0.10020854,0.0047966675,0.00007797396,0.0063396497,0.00015939579,0.10581887],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988637,0.000055728153,0.000058702462,0.000057126636,0.000630706,0.00033400144],"domain_scores_gemma":[0.99550986,0.00047379333,0.00032737522,0.000038000733,0.0018312094,0.0018197333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006317117,0.00014539502,0.00025577954,0.0008878676,0.0013490726,0.0014037911,0.0007040215,0.0013775469,0.011092086],"category_scores_gemma":[0.0027380043,0.00019786926,0.00038503943,0.0017002715,0.0008851253,0.0005116445,0.00031634158,0.002594047,0.0006041943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021087509,0.00031588998,0.043003574,0.0007482444,0.000091506874,0.0017082364,0.0004895452,0.00041477737,0.0020810985,0.0028400414,0.7391116,0.20708667],"study_design_scores_gemma":[0.0011018415,0.0005071732,0.3204673,0.0010273692,0.00031323757,0.0011005771,0.002057445,0.0008034137,0.0015721947,0.0007977676,0.67014617,0.000105623905],"about_ca_topic_score_codex":0.9675472,"about_ca_topic_score_gemma":0.9905786,"teacher_disagreement_score":0.03245282,"about_ca_system_score_codex":0.022163674,"about_ca_system_score_gemma":0.07066268,"threshold_uncertainty_score":0.16080946},"labels":[],"label_agreement":null},{"id":"W4230978315","doi":"10.1007/bf03280259","title":"Prescription drug spending in Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medical prescription; Drug; Prescription drug; Health economics; Public health; Business; Public economics; Economics; Medicine; Pharmacology; Nursing","score_opus":0.05390289870986077,"score_gpt":0.31511780977051973,"score_spread":0.26121491106065897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230978315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6375358,0.019454068,0.00024374519,0.15502113,0.0011444903,0.00014371774,0.10231396,0.00017701674,0.083966084],"genre_scores_gemma":[0.93429595,0.008359473,0.00027736707,0.0074718506,0.00035563318,0.000044285378,0.011472712,0.000053849086,0.037668996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699354,0.00013528587,0.00015326301,0.0001984014,0.0012979896,0.0012214318],"domain_scores_gemma":[0.9924077,0.0003943519,0.00083083357,0.000101186415,0.003562343,0.0027034963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093308394,0.00033411928,0.00069742,0.0034920124,0.0031282967,0.0048185275,0.0011983041,0.001969986,0.008427031],"category_scores_gemma":[0.006296838,0.00049631426,0.001084854,0.006964178,0.00082082837,0.0008208624,0.0010952047,0.0023226852,0.0005104851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008712236,0.00030752513,0.5690576,0.0005814941,0.0006418344,0.0007470342,0.001289997,0.0046067135,0.00040978956,0.03292601,0.32821563,0.06034509],"study_design_scores_gemma":[0.00012328594,0.00004890879,0.8993303,0.00021928326,0.00018894892,0.0001711228,0.0012431912,0.0026173461,0.0002517497,0.00090048276,0.09482861,0.00007669612],"about_ca_topic_score_codex":0.9979962,"about_ca_topic_score_gemma":0.99914813,"teacher_disagreement_score":0.13862798,"about_ca_system_score_codex":0.13862798,"about_ca_system_score_gemma":0.18030071,"threshold_uncertainty_score":0.99906945},"labels":[],"label_agreement":null},{"id":"W4231037796","doi":"10.1007/s40274-017-4376-y","title":"Addition of palbociclib to letrozole not cost effective in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Letrozole; Quality of Life Research; Medicine; Public health; Internal medicine; Cancer; Breast cancer","score_opus":0.019636002678375175,"score_gpt":0.3615838674096126,"score_spread":0.34194786473123745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231037796","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29050604,0.05783166,0.00079740887,0.44493213,0.0049576573,0.0005268908,0.03432496,0.0005346132,0.16558862],"genre_scores_gemma":[0.8433575,0.035959497,0.0023042315,0.06326659,0.0017033459,0.00013571001,0.008090947,0.00022556179,0.04495653],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983516,0.00014356886,0.00009667129,0.0001267589,0.0008095115,0.00047195292],"domain_scores_gemma":[0.9931092,0.0009007894,0.0005683538,0.00009226546,0.0025420573,0.0027872745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010591071,0.00027343683,0.000669869,0.001057689,0.0012671853,0.0023141538,0.0011584073,0.0013018053,0.013938935],"category_scores_gemma":[0.0074285585,0.00039601966,0.00095349853,0.002266936,0.0008614045,0.0005989259,0.00045046178,0.0028041892,0.00052916794],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010712676,0.00046162563,0.06378755,0.0016534113,0.0008470214,0.0016222211,0.00030167509,0.0036133893,0.0024397976,0.009300151,0.6068132,0.29844734],"study_design_scores_gemma":[0.0074943407,0.0015969068,0.34575632,0.0021808713,0.0027451313,0.0012793083,0.001542091,0.005132933,0.0035790342,0.0029861075,0.6254625,0.0002443654],"about_ca_topic_score_codex":0.9834567,"about_ca_topic_score_gemma":0.9944733,"teacher_disagreement_score":0.073015906,"about_ca_system_score_codex":0.073015906,"about_ca_system_score_gemma":0.15708312,"threshold_uncertainty_score":0.52976996},"labels":[],"label_agreement":null},{"id":"W4231445442","doi":"10.1007/bf03269629","title":"Canadian primary healthcare initiatives target of funding","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Primary care; Business; Health economics; Health care; Public health; Medicine; Nursing; Economics; Economic growth; Family medicine","score_opus":0.08296956919041963,"score_gpt":0.45379982231416943,"score_spread":0.3708302531237498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231445442","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006999428,0.006155909,0.0006653367,0.520679,0.016771488,0.00039592976,0.00964837,0.00081267406,0.4378719],"genre_scores_gemma":[0.08336108,0.005906822,0.0023545118,0.11483946,0.004533998,0.0003429307,0.006119441,0.0003032171,0.78223854],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98419535,0.00061744,0.00025891935,0.0004461363,0.009499461,0.0049826996],"domain_scores_gemma":[0.94962615,0.0021459267,0.00076724205,0.0006870898,0.02402732,0.022746276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054593394,0.0010527626,0.0008533721,0.004137988,0.009155021,0.007653783,0.0025911299,0.010891791,0.060120717],"category_scores_gemma":[0.021579698,0.0007349061,0.0011515229,0.003336108,0.0018245487,0.0017290349,0.0033819554,0.0070943558,0.0075033233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039447306,0.000027398715,0.0012119523,0.00010586408,0.000012727948,0.000089221845,0.000135713,0.00005587265,0.00008056856,0.011731078,0.9739329,0.012577187],"study_design_scores_gemma":[0.00007803826,0.000024664683,0.012636643,0.00016767235,0.000025737821,0.000073026305,0.0004112669,0.0001475231,0.00013958817,0.0011709179,0.985103,0.00002203304],"about_ca_topic_score_codex":0.9652938,"about_ca_topic_score_gemma":0.98501694,"teacher_disagreement_score":0.075030595,"about_ca_system_score_codex":0.075030595,"about_ca_system_score_gemma":0.39137134,"threshold_uncertainty_score":0.5443876},"labels":[],"label_agreement":null},{"id":"W4231931420","doi":"10.1007/bf03277078","title":"Cautions over Canadian Rx imports, prices substantially lower","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Agricultural Economics and Policy","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Economics; Public health; Medicine","score_opus":0.016877721643222102,"score_gpt":0.2708490735879757,"score_spread":0.2539713519447536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231931420","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01255247,0.0065052644,0.0006536554,0.8455814,0.012400386,0.00004337364,0.003148491,0.00066036853,0.118454605],"genre_scores_gemma":[0.10167917,0.007325173,0.0023431922,0.65636075,0.009867156,0.00004760693,0.0021564472,0.0004487888,0.21977164],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533856,0.00023907411,0.0002320098,0.0003645558,0.003107616,0.0007182145],"domain_scores_gemma":[0.990884,0.0023019041,0.00059944304,0.0003312296,0.004740734,0.001142694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00327111,0.0006584727,0.00060336565,0.001173924,0.0041901334,0.006182243,0.0015280596,0.010282112,0.022892354],"category_scores_gemma":[0.02106175,0.00051779236,0.0014098193,0.0020003924,0.0022549082,0.0017595339,0.0007675772,0.011380847,0.002811574],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022071735,0.000015732425,0.0018324192,0.00011832234,0.000041534495,0.0002306923,0.00019377966,0.00016999757,0.0011359904,0.014594483,0.96079886,0.020647425],"study_design_scores_gemma":[0.00008424538,0.000050216117,0.013093868,0.00018212994,0.00007802199,0.00019651724,0.0004152083,0.00017333079,0.0011934906,0.0014772334,0.9829927,0.00006303487],"about_ca_topic_score_codex":0.8696332,"about_ca_topic_score_gemma":0.92521614,"teacher_disagreement_score":0.1303668,"about_ca_system_score_codex":0.022766156,"about_ca_system_score_gemma":0.049668502,"threshold_uncertainty_score":0.26226908},"labels":[],"label_agreement":null},{"id":"W4232189755","doi":"10.2165/00151234-200604940-00026","title":"Lost productivity drives schizophrenia burden in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Productivity; Schizophrenia (object-oriented programming); Public health; Economics; Psychiatry; Business; Public economics; Medicine; Economic growth","score_opus":0.11681680249891628,"score_gpt":0.39537867890253353,"score_spread":0.27856187640361724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232189755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7814242,0.015065397,0.00045271788,0.13628164,0.0010435336,0.00015736365,0.01998353,0.00009808491,0.045493472],"genre_scores_gemma":[0.9821014,0.006067582,0.00024584713,0.0033936352,0.00026288506,0.000020810312,0.0021253782,0.000028791039,0.0057536764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779,0.00017646745,0.00011770513,0.00011070869,0.00081679085,0.000988333],"domain_scores_gemma":[0.9878494,0.0005265031,0.0017433998,0.00015427242,0.0053167343,0.004409576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010878873,0.000259356,0.00065997243,0.0030025754,0.0039728056,0.0030957416,0.001290053,0.0010177202,0.008727112],"category_scores_gemma":[0.009874282,0.00042767543,0.0009573072,0.0051333974,0.0010900783,0.0009136329,0.0016065837,0.0023560745,0.00046545768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005498353,0.00013417705,0.84801435,0.0002567486,0.00027946985,0.00064558635,0.0016261777,0.0014721543,0.00027718025,0.0069276593,0.076564595,0.063252084],"study_design_scores_gemma":[0.000088489156,0.0000504398,0.97414804,0.0003358825,0.00016777053,0.00022598653,0.0034997307,0.0016692381,0.000094358234,0.0016207325,0.018044721,0.000054612647],"about_ca_topic_score_codex":0.9965502,"about_ca_topic_score_gemma":0.9981268,"teacher_disagreement_score":0.08806133,"about_ca_system_score_codex":0.08806133,"about_ca_system_score_gemma":0.13472271,"threshold_uncertainty_score":0.6389327},"labels":[],"label_agreement":null},{"id":"W4232246152","doi":"10.1007/s40274-016-2750-9","title":"Analysing high-cost users of healthcare in Canada","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Business; Health care; Public health; Health administration; Computer science; Nursing; Medicine; Economics; Economic growth","score_opus":0.05158430184563264,"score_gpt":0.3235502121192386,"score_spread":0.271965910273606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232246152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791285,0.0022311066,0.00035067945,0.005422745,0.000030502197,0.00006552263,0.009410315,0.000026408328,0.003334307],"genre_scores_gemma":[0.9914431,0.0010261624,0.00029170548,0.0004299477,0.000029032817,0.00002024607,0.00389704,0.000020815749,0.0028418484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738914,0.0003454728,0.00014494592,0.00019178697,0.00056174304,0.0013669279],"domain_scores_gemma":[0.989994,0.0027855264,0.0016579016,0.00021441984,0.0025709101,0.0027773338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013882212,0.0005471337,0.0010360256,0.0028423732,0.002545496,0.005011195,0.0026084909,0.0023360404,0.0049747676],"category_scores_gemma":[0.009853628,0.0008235227,0.0011714658,0.011261061,0.0013554643,0.0013236828,0.0020418074,0.0029932575,0.00032102742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055720867,0.00041137842,0.9284024,0.00029084974,0.0006880038,0.0013840456,0.0026351493,0.024970975,0.00022677315,0.00996378,0.016943045,0.013526479],"study_design_scores_gemma":[0.00008018396,0.00008008484,0.9241635,0.0001980173,0.00028027684,0.00025144758,0.016878454,0.04616049,0.00024919567,0.0014230444,0.010112577,0.00012270504],"about_ca_topic_score_codex":0.9974738,"about_ca_topic_score_gemma":0.9980319,"teacher_disagreement_score":0.095420726,"about_ca_system_score_codex":0.095420726,"about_ca_system_score_gemma":0.06124233,"threshold_uncertainty_score":0.69232905},"labels":[],"label_agreement":null},{"id":"W4233084705","doi":"10.1007/s40274-016-2726-9","title":"Mental health associated with higher healthcare costs in Canada","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Health economics; Public health; Mental healthcare; Mental health; Health administration; Business; Environmental health; Medicine; Psychiatry; Nursing; Economics; Economic growth","score_opus":0.04309049664462562,"score_gpt":0.31216293918346,"score_spread":0.2690724425388344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233084705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89310503,0.008864019,0.00019767061,0.053803876,0.00062951376,0.00009604699,0.02548777,0.000048725193,0.017767286],"genre_scores_gemma":[0.9842514,0.0032587862,0.0001872789,0.0036206197,0.000202357,0.000022388358,0.004048723,0.00002568704,0.0043826634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979225,0.00013381391,0.00014630967,0.00015720435,0.00052526215,0.0011150069],"domain_scores_gemma":[0.9884322,0.0006003972,0.002617837,0.00015769902,0.0039754286,0.004216288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061440165,0.00036247654,0.00069232425,0.0023406302,0.0032917277,0.0032355832,0.0015730013,0.001821907,0.009286986],"category_scores_gemma":[0.0063019185,0.0005992599,0.0020005552,0.005815478,0.0010205508,0.000786361,0.0015762812,0.004132396,0.00023406974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041371575,0.00019229791,0.9396178,0.00017670903,0.0005244786,0.00051679165,0.00058496115,0.0010793083,0.00010897364,0.0030741051,0.0416198,0.012091157],"study_design_scores_gemma":[0.000076086624,0.000027426158,0.99133533,0.00017621029,0.00017234062,0.00016169656,0.0014868631,0.0011703229,0.000048094902,0.0003736129,0.0049197376,0.000052376974],"about_ca_topic_score_codex":0.9984577,"about_ca_topic_score_gemma":0.9991296,"teacher_disagreement_score":0.09119777,"about_ca_system_score_codex":0.09119777,"about_ca_system_score_gemma":0.10524061,"threshold_uncertainty_score":0.66168916},"labels":[],"label_agreement":null},{"id":"W4233304861","doi":"10.1007/bf03276005","title":"Opioid analgesics underused for neuropathic pain in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Medicine; Opioid; Pain management; Quality of Life Research; Anesthesia; Intensive care medicine; Public health; Nursing; Internal medicine","score_opus":0.024951935013929692,"score_gpt":0.30406136471552836,"score_spread":0.2791094297015987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233304861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7735874,0.026763244,0.00023294215,0.12396892,0.0017012098,0.0001356774,0.009427621,0.00009301381,0.0640899],"genre_scores_gemma":[0.9435633,0.0178151,0.00034484066,0.020852452,0.0008317443,0.000023514462,0.0019007323,0.00003890506,0.014629503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989674,0.000052522224,0.00007340816,0.000042685286,0.00049577217,0.00036823942],"domain_scores_gemma":[0.9940316,0.00047609213,0.0009455594,0.00003484271,0.0025029124,0.0020089285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032251858,0.00014332477,0.0002756292,0.0013870404,0.0020842934,0.0014720114,0.0007501456,0.001065966,0.004973349],"category_scores_gemma":[0.00310415,0.0002761329,0.0003257916,0.0036397509,0.000640001,0.000514646,0.0004903591,0.0018149752,0.00019776552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061231083,0.00025689142,0.79661906,0.00047860926,0.00016898455,0.0028000353,0.0012848418,0.00045597926,0.0006923855,0.0016608775,0.11061054,0.0843595],"study_design_scores_gemma":[0.00012969962,0.00008325764,0.94396573,0.00030429242,0.00017461133,0.000984962,0.0032614614,0.0007294063,0.00027564666,0.00019396513,0.049849264,0.000047788966],"about_ca_topic_score_codex":0.99217916,"about_ca_topic_score_gemma":0.9976877,"teacher_disagreement_score":0.03031008,"about_ca_system_score_codex":0.03031008,"about_ca_system_score_gemma":0.06902408,"threshold_uncertainty_score":0.21991605},"labels":[],"label_agreement":null},{"id":"W4233363111","doi":"10.1007/s40274-020-6608-9","title":"Screening for congenital adrenal hyperplasia cost effective in Canada","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Congenital adrenal hyperplasia; Quality of Life Research; Medicine; Hyperplasia; Public health; Internal medicine; Pathology","score_opus":0.021459879655402664,"score_gpt":0.30667880108023204,"score_spread":0.2852189214248294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233363111","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11778925,0.036236532,0.0004095311,0.6950973,0.008167506,0.00020440937,0.014965777,0.0004503463,0.12667935],"genre_scores_gemma":[0.73797756,0.061619706,0.002205684,0.11655821,0.0062957653,0.00010319535,0.007249118,0.00021858605,0.06777217],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975048,0.00015334919,0.00011421579,0.000096736796,0.0015014407,0.0006293604],"domain_scores_gemma":[0.9841314,0.0021400421,0.0007717985,0.00012911756,0.0056296987,0.0071979095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009813005,0.00034313233,0.00043690918,0.0018382829,0.0017023156,0.0028789928,0.0013253185,0.0025824266,0.015837466],"category_scores_gemma":[0.011154092,0.00042255683,0.0007474124,0.002457833,0.0010413453,0.0006923259,0.000848863,0.002571274,0.0004887378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058804447,0.00021377022,0.09347421,0.0007047623,0.000213748,0.0019078242,0.000357838,0.0016528991,0.0006595018,0.0059887627,0.7356978,0.15854086],"study_design_scores_gemma":[0.0009498483,0.00033714698,0.62859184,0.0021982533,0.0006485976,0.0019521635,0.0024674553,0.0044830875,0.0007309964,0.0026208272,0.35483885,0.00018104538],"about_ca_topic_score_codex":0.98623496,"about_ca_topic_score_gemma":0.9926352,"teacher_disagreement_score":0.054630868,"about_ca_system_score_codex":0.054630868,"about_ca_system_score_gemma":0.16206405,"threshold_uncertainty_score":0.39637655},"labels":[],"label_agreement":null},{"id":"W4233484819","doi":"10.2165/00151234-201106250-00011","title":"Dabigatran etexilate highly cost effective in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Quality of Life Research; Computer science; Medicine; Public health; Internal medicine","score_opus":0.060221816165151834,"score_gpt":0.3435310277547639,"score_spread":0.2833092115896121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233484819","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34037894,0.037490074,0.0008826622,0.42953187,0.0037418634,0.00036747492,0.017945882,0.00035059388,0.16931063],"genre_scores_gemma":[0.8807424,0.028312245,0.0020330313,0.0356056,0.0018432509,0.00006610283,0.004562577,0.00011608492,0.04671865],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99844724,0.000116450756,0.00010118652,0.000068184214,0.00085004163,0.00041688187],"domain_scores_gemma":[0.9909684,0.00094277237,0.00051772356,0.00010505532,0.0038005486,0.0036654675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007034463,0.00020692733,0.0003181897,0.00107645,0.0010193906,0.0021709877,0.0006749166,0.00093695126,0.008706864],"category_scores_gemma":[0.0065635405,0.000267193,0.00040416967,0.0019328136,0.00071322726,0.0005378369,0.00047562414,0.0017714545,0.0003195227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026296203,0.00050310715,0.15214832,0.0008314405,0.00042234745,0.0023665284,0.00046146978,0.0031646304,0.0021651261,0.014737699,0.5067107,0.31385896],"study_design_scores_gemma":[0.0018732199,0.00043972814,0.62379664,0.000766311,0.0005059587,0.0009671275,0.0011314066,0.003992273,0.0012222525,0.0020159667,0.36316824,0.00012087296],"about_ca_topic_score_codex":0.9796682,"about_ca_topic_score_gemma":0.9899804,"teacher_disagreement_score":0.03994472,"about_ca_system_score_codex":0.03994472,"about_ca_system_score_gemma":0.12826651,"threshold_uncertainty_score":0.2898206},"labels":[],"label_agreement":null},{"id":"W4233544818","doi":"10.1007/bf03276687","title":"Healthcare administration costs huge in the US vs Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Quality and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health administration; Quality of Life Research; Health care; Administration (probate law); Health economics; Business; Public health; Public administration; Public economics; Medicine; Economics; Political science; Economic growth; Nursing; Law","score_opus":0.08790370956313619,"score_gpt":0.4825034681273154,"score_spread":0.3945997585641792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233544818","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10126673,0.021530587,0.0005001831,0.6805362,0.006115542,0.000047562164,0.0037693868,0.00023804748,0.18599577],"genre_scores_gemma":[0.7669352,0.019071665,0.0011947559,0.12619568,0.0023696744,0.000024580464,0.002405229,0.0002017774,0.08160139],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970319,0.00019533969,0.00008924542,0.00012313013,0.0016101331,0.0009502423],"domain_scores_gemma":[0.98787063,0.0012599373,0.00058417994,0.00016879523,0.004166166,0.005950353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011910185,0.00031103072,0.00050298474,0.0016981823,0.0043960204,0.006857806,0.00082633947,0.0039424584,0.014913541],"category_scores_gemma":[0.009758122,0.0003046098,0.00065052905,0.0029453363,0.0017500577,0.0015845199,0.0011084033,0.0051487624,0.00068384997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059028744,0.00009521592,0.043759424,0.0003121441,0.00017255392,0.00064413046,0.0007179828,0.0010115601,0.0005162525,0.036431484,0.7912499,0.12449902],"study_design_scores_gemma":[0.00018527886,0.00011556953,0.24042188,0.00081607566,0.00032711696,0.0007369993,0.009836334,0.0015799323,0.00070752774,0.0069875447,0.7381259,0.00015980355],"about_ca_topic_score_codex":0.97210306,"about_ca_topic_score_gemma":0.9902774,"teacher_disagreement_score":0.055768967,"about_ca_system_score_codex":0.055768967,"about_ca_system_score_gemma":0.10558045,"threshold_uncertainty_score":0.40463406},"labels":[],"label_agreement":null},{"id":"W4234163504","doi":"10.1007/bf03267040","title":"Canada's health system restricts drug access","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Drug; Health economics; Business; Environmental health; Medicine; Pharmacology; Nursing","score_opus":0.05204346335349221,"score_gpt":0.34481938233646964,"score_spread":0.29277591898297745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234163504","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041066624,0.008312582,0.0015390294,0.5354985,0.0034096197,0.0001769682,0.008334681,0.0004646578,0.40119737],"genre_scores_gemma":[0.4262327,0.007771613,0.0021781898,0.37567163,0.0025117644,0.00012054962,0.0020151967,0.00015819947,0.18334018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98560065,0.0007297535,0.00032926776,0.0006905053,0.009003436,0.00364635],"domain_scores_gemma":[0.9684341,0.0112588005,0.0016549665,0.0008113297,0.010168128,0.007672726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043313145,0.00052619964,0.0009906306,0.0030842624,0.0060197655,0.010402672,0.0020499562,0.009025042,0.02326279],"category_scores_gemma":[0.028188666,0.0007242109,0.0016804865,0.0035474403,0.0038906028,0.0018606766,0.002301207,0.0070365,0.0013867742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001911735,0.00008360207,0.015723346,0.0002671791,0.00015208287,0.000316894,0.00047340855,0.0015049184,0.00062010373,0.16769354,0.78382456,0.029149188],"study_design_scores_gemma":[0.00024505644,0.00009003516,0.06679459,0.00036695492,0.00019783957,0.00022661944,0.000848301,0.0022368273,0.0009097132,0.017803164,0.91012424,0.00015664478],"about_ca_topic_score_codex":0.9877893,"about_ca_topic_score_gemma":0.99216,"teacher_disagreement_score":0.9285629,"about_ca_system_score_codex":0.07143713,"about_ca_system_score_gemma":0.19191836,"threshold_uncertainty_score":0.5183151},"labels":[],"label_agreement":null},{"id":"W4234530602","doi":"10.1007/s40274-013-0236-6","title":"Pharmacists could save Ontario's public health system big $","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Health economics; Business; Environmental health; Medicine; Nursing","score_opus":0.160703422337893,"score_gpt":0.34024375975838494,"score_spread":0.17954033742049194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234530602","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009339008,0.0014849618,0.000581741,0.8648777,0.0074121137,0.00012558106,0.0036673767,0.0004807419,0.112030715],"genre_scores_gemma":[0.15338826,0.0036422347,0.0019374973,0.38792196,0.00754721,0.00016458065,0.003663242,0.00029246535,0.44144264],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961826,0.0005241541,0.00010338407,0.00014616216,0.0018262631,0.0012173009],"domain_scores_gemma":[0.9848263,0.002198373,0.0006376597,0.0006061418,0.004154547,0.007576929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038556915,0.00076562056,0.00046109682,0.0009524549,0.00414986,0.0074099307,0.0011913175,0.011447667,0.05447774],"category_scores_gemma":[0.02076373,0.0005854442,0.001638427,0.000985742,0.0022904824,0.0024841346,0.0019395503,0.0050132186,0.0070454506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001604427,0.000051181232,0.0022044256,0.000054979824,0.000040542556,0.00007814753,0.00005900466,0.00031735585,0.00011955937,0.0065904353,0.9788754,0.011448474],"study_design_scores_gemma":[0.000344663,0.00011607487,0.017017068,0.00018108287,0.00007647871,0.0000843529,0.0006684341,0.001140638,0.00026671583,0.006648589,0.9733984,0.00005754497],"about_ca_topic_score_codex":0.79275423,"about_ca_topic_score_gemma":0.8948306,"teacher_disagreement_score":0.96295136,"about_ca_system_score_codex":0.03704865,"about_ca_system_score_gemma":0.13113934,"threshold_uncertainty_score":0.41693252},"labels":[],"label_agreement":null},{"id":"W4234596508","doi":"10.2165/00151234-200504830-00043","title":"Trastuzumab to be provided free in British Columbia","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.04803241967852492,"score_gpt":0.3218295073160283,"score_spread":0.2737970876375034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234596508","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7716814,0.0075481315,0.00025485002,0.07113916,0.00089189626,0.00017248228,0.021408135,0.0001102073,0.12679371],"genre_scores_gemma":[0.8341144,0.003753908,0.00027869988,0.01499185,0.000118419666,0.00008084952,0.0039305664,0.00006218665,0.14266913],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977564,0.00017906952,0.00009956983,0.00016712428,0.0004651051,0.001332753],"domain_scores_gemma":[0.99404955,0.0009625307,0.00041735455,0.00012277634,0.0013397213,0.0031080847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011572929,0.00017603152,0.00048477235,0.0013865689,0.0028219873,0.0030809226,0.0013976584,0.0024169395,0.010780544],"category_scores_gemma":[0.0058278088,0.00046538824,0.00047674507,0.0026354953,0.00063197874,0.0006191986,0.0010450742,0.0036957879,0.0007794162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004006142,0.00065074174,0.38844222,0.00058580865,0.0003111154,0.0050090603,0.0020273966,0.0043718345,0.0020422046,0.030816998,0.43697596,0.12476054],"study_design_scores_gemma":[0.0004606534,0.00014325517,0.80758923,0.00052258756,0.00022447905,0.000778065,0.00553667,0.003380492,0.0009918951,0.0018435925,0.17837396,0.00015498117],"about_ca_topic_score_codex":0.9864422,"about_ca_topic_score_gemma":0.9960251,"teacher_disagreement_score":0.052462406,"about_ca_system_score_codex":0.052462406,"about_ca_system_score_gemma":0.06776875,"threshold_uncertainty_score":0.3806432},"labels":[],"label_agreement":null},{"id":"W4234833161","doi":"10.2165/00151234-201206550-00032","title":"Benefits of Crestor card continue in Canada","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine","score_opus":0.05884608121265341,"score_gpt":0.3099594378561737,"score_spread":0.2511133566435203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234833161","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18802495,0.0058554304,0.000908069,0.4875914,0.009670619,0.0003579687,0.019962326,0.0010032465,0.28662598],"genre_scores_gemma":[0.55964196,0.003950856,0.0012271573,0.103293404,0.0029812916,0.00007470589,0.006596885,0.00024849415,0.32198524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99496377,0.00017807922,0.000120491684,0.00020806471,0.0024632784,0.0020663375],"domain_scores_gemma":[0.9795266,0.0017806896,0.00069985405,0.00049288524,0.007493159,0.010006693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002869945,0.0003219604,0.00051651394,0.0013738634,0.0032615827,0.0068003647,0.0022496113,0.0064421697,0.03453419],"category_scores_gemma":[0.013353558,0.00039743772,0.0010645575,0.0016942759,0.001754597,0.0014108797,0.001849307,0.004720309,0.003080498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087192684,0.00020735296,0.028004762,0.00018571637,0.00006913911,0.0007510833,0.00035890783,0.0008060307,0.00041631892,0.026156249,0.88808995,0.05408259],"study_design_scores_gemma":[0.0005655136,0.00020701582,0.09795502,0.00028015225,0.00012893142,0.00028806116,0.0015173657,0.0020198054,0.00063036237,0.0020923286,0.89420533,0.00011011936],"about_ca_topic_score_codex":0.94752985,"about_ca_topic_score_gemma":0.9771922,"teacher_disagreement_score":0.052470148,"about_ca_system_score_codex":0.034561533,"about_ca_system_score_gemma":0.11760441,"threshold_uncertainty_score":0.25076264},"labels":[],"label_agreement":null},{"id":"W4235063194","doi":"10.1007/s40274-018-5025-9","title":"Midostaurin a cost-effective option for AML in Canada","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Midostaurin; Medicine; Public health; Leukemia; Internal medicine; Nursing","score_opus":0.015649525705426055,"score_gpt":0.35152467229114187,"score_spread":0.3358751465857158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235063194","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15639657,0.06957985,0.0014968024,0.58296084,0.00641955,0.0003906927,0.0068327542,0.0005453293,0.17537767],"genre_scores_gemma":[0.73965216,0.075794086,0.0038510012,0.06700533,0.003964581,0.000098534474,0.0054431744,0.00016267775,0.10402846],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995004,0.000027697897,0.00002044903,0.00003734286,0.00023498954,0.00017912131],"domain_scores_gemma":[0.998279,0.00009964953,0.00007540155,0.000014312692,0.0003199782,0.0012115677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032108708,0.00021524905,0.00031972927,0.0006642134,0.0011695604,0.0014208663,0.0008305257,0.0015298816,0.019626101],"category_scores_gemma":[0.0013373533,0.00014572813,0.0005285882,0.00096092164,0.00080031424,0.00041170442,0.0005392203,0.0020778358,0.0010369478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032599831,0.00048605097,0.015171023,0.00050460076,0.00013897229,0.004340505,0.00015958252,0.0017185656,0.005799689,0.016037969,0.5249902,0.4273929],"study_design_scores_gemma":[0.00222679,0.0009201256,0.084639005,0.0007758912,0.00025250038,0.0032573782,0.00072858244,0.0020270147,0.0019508051,0.004153409,0.8989401,0.00012838059],"about_ca_topic_score_codex":0.82672435,"about_ca_topic_score_gemma":0.94078803,"teacher_disagreement_score":0.17327565,"about_ca_system_score_codex":0.026532952,"about_ca_system_score_gemma":0.056046173,"threshold_uncertainty_score":0.34859216},"labels":[],"label_agreement":null},{"id":"W4235510047","doi":"10.2165/00151234-200705250-00014","title":"Pregnancy during isotretinoin use “frequent” in Canada","year":2007,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Isotretinoin; Pregnancy; Medicine; Public health; Obstetrics; Dermatology; Nursing","score_opus":0.012392086816790686,"score_gpt":0.28151399104628083,"score_spread":0.26912190422949017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235510047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9343597,0.00807314,0.00021299486,0.027655179,0.00055151223,0.00010975983,0.0066978554,0.000062232975,0.022277668],"genre_scores_gemma":[0.9855952,0.0053513534,0.0002383013,0.0041175834,0.00020187639,0.00002375882,0.0010150911,0.000020223048,0.0034366858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991875,0.000060851708,0.00006284661,0.00007542894,0.00023871848,0.00037459825],"domain_scores_gemma":[0.99698514,0.00032673203,0.00068991893,0.00004013769,0.00071732,0.0012407443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030824606,0.00013126315,0.00030755915,0.00091003184,0.002516883,0.0010891805,0.0006656922,0.0011849598,0.00359328],"category_scores_gemma":[0.0031083478,0.00029205394,0.00033009954,0.0026128974,0.00055746787,0.00036542327,0.00049962936,0.0017902052,0.00017066876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032619757,0.00009454862,0.94799644,0.00013811533,0.00005821362,0.003282156,0.0016715664,0.00017895472,0.00044910124,0.0006744406,0.014759366,0.030370886],"study_design_scores_gemma":[0.000029786743,0.00005219333,0.98739225,0.00022331964,0.00003731747,0.0013703202,0.0039759013,0.00027322816,0.00013155669,0.00010888578,0.0063750218,0.00003020885],"about_ca_topic_score_codex":0.98218775,"about_ca_topic_score_gemma":0.99283445,"teacher_disagreement_score":0.017812252,"about_ca_system_score_codex":0.017695274,"about_ca_system_score_gemma":0.03413719,"threshold_uncertainty_score":0.12838882},"labels":[],"label_agreement":null},{"id":"W4235534330","doi":"10.2165/00151234-200404500-00049","title":"Medical association welcomes Canadian govt funding initiative","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Association (psychology); Public health; Health economics; Business; Medicine; Psychology","score_opus":0.07055426202808049,"score_gpt":0.4584102226975196,"score_spread":0.38785596066943906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235534330","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025459484,0.0024642008,0.00038380743,0.4932914,0.049660157,0.00030046157,0.00621309,0.0010683944,0.44407266],"genre_scores_gemma":[0.0055980245,0.000704683,0.00039986186,0.057708666,0.002821046,0.00007819915,0.0015118768,0.00017552845,0.9310022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98856634,0.0004060793,0.0001770662,0.0003682168,0.007742229,0.002739947],"domain_scores_gemma":[0.9706067,0.0026814118,0.0004051007,0.0007485902,0.012434983,0.013123217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006055507,0.0008822137,0.00091818883,0.0032467411,0.008914652,0.011827746,0.002812177,0.027842915,0.14358085],"category_scores_gemma":[0.019605074,0.00086024054,0.0013478673,0.0016688894,0.0019140536,0.0017164848,0.0037540721,0.010708215,0.0453974],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018773548,0.000019847263,0.00013644762,0.0000109897655,0.0000020977736,0.000037216316,0.000013051043,0.000009701673,0.000025931422,0.0021911506,0.9937954,0.0037394206],"study_design_scores_gemma":[0.000055341807,0.000013964244,0.0016627507,0.000047669324,0.000007215272,0.000029760344,0.000102318416,0.00007344208,0.000055955028,0.00074603857,0.9971897,0.000015923672],"about_ca_topic_score_codex":0.716438,"about_ca_topic_score_gemma":0.8886063,"teacher_disagreement_score":0.9720697,"about_ca_system_score_codex":0.027930295,"about_ca_system_score_gemma":0.18429215,"threshold_uncertainty_score":0.5704639},"labels":[],"label_agreement":null},{"id":"W4235709219","doi":"10.2165/00151234-201106430-00009","title":"First-line tenofovir best for chronic hepatitis B in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tenofovir; Chronic hepatitis; Quality of Life Research; Medicine; Virology; Public health; Human immunodeficiency virus (HIV); Virus; Nursing","score_opus":0.051749024554450594,"score_gpt":0.3229490111454052,"score_spread":0.2711999865909546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235709219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7759268,0.08622973,0.00024933062,0.07454754,0.0013901016,0.00049199344,0.027339527,0.0000755673,0.033749316],"genre_scores_gemma":[0.94939756,0.031897385,0.0005915806,0.007492403,0.0002907936,0.00010309848,0.0037747999,0.000028424449,0.0064239935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845064,0.00024237102,0.00012887803,0.000089764486,0.0005705933,0.0005177119],"domain_scores_gemma":[0.99169636,0.0009315488,0.0008955466,0.00010600102,0.0029281194,0.0034424176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014805843,0.0002644478,0.000952463,0.0014282416,0.002442148,0.0019331741,0.0013011899,0.0009952731,0.0055251555],"category_scores_gemma":[0.00687465,0.0003235515,0.0010456204,0.004254187,0.0006645087,0.0007877001,0.00063144474,0.0021009082,0.00017974841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01326055,0.0014001651,0.60341114,0.003607612,0.0015204649,0.0012485422,0.0014230027,0.0020089776,0.00089988485,0.0045831515,0.13825916,0.2283774],"study_design_scores_gemma":[0.004199083,0.0011278384,0.93955857,0.0024385345,0.0015330719,0.00048558429,0.0045973277,0.0013940871,0.000587023,0.0006130194,0.043328978,0.00013688237],"about_ca_topic_score_codex":0.9950138,"about_ca_topic_score_gemma":0.9979511,"teacher_disagreement_score":0.06283198,"about_ca_system_score_codex":0.06283198,"about_ca_system_score_gemma":0.12627785,"threshold_uncertainty_score":0.4558801},"labels":[],"label_agreement":null},{"id":"W4236444549","doi":"10.1007/bf03275733","title":"Resource use low among Canadian women with psychiatric disorders","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Psychiatry; Resource (disambiguation); Public health; Resource use; Psychology; Medicine; Computer science; Economics; Nursing","score_opus":0.014263721691507206,"score_gpt":0.3104943048282689,"score_spread":0.2962305831367617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236444549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115455,0.0056565306,0.00013404715,0.038693104,0.00037053032,0.00006361094,0.013189384,0.000035368947,0.030311938],"genre_scores_gemma":[0.9898527,0.0022271047,0.00016214818,0.00311108,0.00006341741,0.000020027488,0.001825046,0.000012713273,0.0027258173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989749,0.00006333328,0.000056497596,0.00007964346,0.00032192635,0.0005038434],"domain_scores_gemma":[0.9970462,0.00023023029,0.00046557165,0.000057350946,0.0012420195,0.00095867924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051570224,0.00026990523,0.0004574646,0.0013708142,0.0046625524,0.0021190192,0.0012325775,0.0011058247,0.0055698063],"category_scores_gemma":[0.0054059746,0.00031847498,0.0007272554,0.0048697274,0.00074519124,0.0006651287,0.0007796628,0.0021393674,0.00029341114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019252414,0.000120156335,0.9355984,0.00012001078,0.00010552038,0.000225958,0.0023394597,0.00016495975,0.00016001247,0.0011314343,0.03452772,0.025313793],"study_design_scores_gemma":[0.000022810576,0.000021114549,0.98549926,0.00014184245,0.00008445755,0.000109106026,0.0058390256,0.00024366853,0.000071651804,0.00026178118,0.0076700407,0.000035208355],"about_ca_topic_score_codex":0.996479,"about_ca_topic_score_gemma":0.9979063,"teacher_disagreement_score":0.03284871,"about_ca_system_score_codex":0.03284871,"about_ca_system_score_gemma":0.044369645,"threshold_uncertainty_score":0.23833519},"labels":[],"label_agreement":null},{"id":"W4236445904","doi":"10.1007/s40274-020-7285-4","title":"Non-invasive prenatal Down syndrome screening \"affordable\" in Canada","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Pathology","score_opus":0.021415011980702923,"score_gpt":0.282073091242399,"score_spread":0.26065807926169604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236445904","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17650153,0.017932003,0.0007731898,0.67182094,0.0061192857,0.00016473455,0.017570628,0.00034471884,0.10877302],"genre_scores_gemma":[0.7101006,0.029921168,0.002642114,0.1371993,0.0028765886,0.00010760294,0.0068632667,0.00021477601,0.11007458],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979219,0.000114297116,0.000080164384,0.0001264213,0.001107839,0.0006493213],"domain_scores_gemma":[0.98617053,0.0019782651,0.00080863456,0.000115167066,0.0042797946,0.00664767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008388942,0.00020532343,0.0003068305,0.00090236025,0.0019827029,0.0025882772,0.00093545445,0.0020335643,0.013247521],"category_scores_gemma":[0.007344151,0.00034272022,0.00048551272,0.0017667103,0.0007774886,0.0006816166,0.0006444305,0.0032937324,0.00042410605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052100664,0.00015973582,0.12818013,0.0006942328,0.000100111334,0.0021187933,0.0011194624,0.0007964384,0.0013839715,0.016497694,0.7159346,0.13249388],"study_design_scores_gemma":[0.00026730372,0.00015424684,0.61589426,0.0010394156,0.00015087111,0.00066281826,0.002643318,0.0018389,0.0005898895,0.0012627081,0.37539363,0.00010254243],"about_ca_topic_score_codex":0.9922913,"about_ca_topic_score_gemma":0.99678516,"teacher_disagreement_score":0.04853429,"about_ca_system_score_codex":0.04853429,"about_ca_system_score_gemma":0.14889027,"threshold_uncertainty_score":0.35214257},"labels":[],"label_agreement":null},{"id":"W4236788575","doi":"10.2165/00151234-200605110-00006","title":"Ezetimibe add-on to atorvastatin: evidence for adoption in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Ezetimibe; Quality of Life Research; Business; Public health; Medicine; Pharmacology; Statin; Internal medicine","score_opus":0.043245420535249504,"score_gpt":0.35861665981557744,"score_spread":0.31537123928032795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236788575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75376576,0.08811021,0.0017603156,0.08562464,0.0016287293,0.00088777643,0.011537212,0.00023744235,0.056447875],"genre_scores_gemma":[0.9522887,0.029129226,0.002173799,0.011005049,0.0002846831,0.00009869218,0.0018561262,0.00008009817,0.0030837336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900579,0.0016006997,0.0008761129,0.00097199634,0.0051911096,0.001302312],"domain_scores_gemma":[0.9329226,0.01981262,0.010800948,0.0014052031,0.026057852,0.009000725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006623536,0.0003924458,0.0011855395,0.0021470564,0.0021645392,0.0037097458,0.002724367,0.0021070442,0.005736545],"category_scores_gemma":[0.057479184,0.0007743111,0.001596163,0.006829526,0.0018871732,0.0013723451,0.0011389268,0.0039501693,0.00025450435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009107064,0.00071389857,0.5660055,0.0034525946,0.0014003519,0.0007537036,0.003086353,0.0011652234,0.0010712191,0.004561197,0.046699263,0.36198363],"study_design_scores_gemma":[0.003924407,0.0010529155,0.9394326,0.003907438,0.004135376,0.00035732356,0.0031960797,0.0027381887,0.001005055,0.0006685003,0.03943128,0.0001508623],"about_ca_topic_score_codex":0.9830634,"about_ca_topic_score_gemma":0.9882267,"teacher_disagreement_score":0.047455844,"about_ca_system_score_codex":0.047455844,"about_ca_system_score_gemma":0.115893155,"threshold_uncertainty_score":0.34431785},"labels":[],"label_agreement":null},{"id":"W4237000794","doi":"10.2165/00151234-201106310-00025","title":"Febuxostat, dexlansoprazole reimbursed in Quebec","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Febuxostat; Quality of Life Research; Business; Medicine; Public health; Internal medicine; Nursing","score_opus":0.04945966627069039,"score_gpt":0.36785061744353953,"score_spread":0.31839095117284916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237000794","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2998433,0.0423394,0.0007006609,0.45220718,0.0074704317,0.00016201033,0.028929822,0.00036831398,0.16797881],"genre_scores_gemma":[0.7449577,0.0234392,0.0014316367,0.06593207,0.0021160156,0.00008576961,0.008226704,0.00010394882,0.15370695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995479,0.000056869143,0.000030651197,0.00004074376,0.00016889011,0.00015499188],"domain_scores_gemma":[0.997255,0.00037249536,0.00026711705,0.00005115249,0.0010666987,0.0009874491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054967747,0.00011235307,0.00019194745,0.00040181875,0.0012122495,0.0014037866,0.00054701924,0.0010176193,0.014681675],"category_scores_gemma":[0.0030631982,0.00012644938,0.0002871187,0.00094048807,0.00038303976,0.0004549968,0.0002672636,0.001317671,0.00045875265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001298533,0.00019003697,0.10463474,0.00036019195,0.00015387856,0.001957734,0.00026617918,0.0011171903,0.001603615,0.0071714506,0.73621523,0.14503114],"study_design_scores_gemma":[0.0006931279,0.00016436483,0.40929502,0.0004066366,0.00013541276,0.0005715119,0.0007666858,0.0019007587,0.00068546186,0.00045602242,0.58486223,0.00006281372],"about_ca_topic_score_codex":0.9786647,"about_ca_topic_score_gemma":0.99046385,"teacher_disagreement_score":0.025333758,"about_ca_system_score_codex":0.025333758,"about_ca_system_score_gemma":0.044752173,"threshold_uncertainty_score":0.18381017},"labels":[],"label_agreement":null},{"id":"W4237553453","doi":"10.2165/00151234-201006130-00020","title":"Insulin initiation: cost-effective options in Canada?","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Insulin; Economics; Public health; Medicine; Internal medicine; Nursing","score_opus":0.02967356865642003,"score_gpt":0.3619676933345514,"score_spread":0.3322941246781314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237553453","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012740842,0.032570872,0.00048099525,0.91343105,0.0026754637,0.00009071855,0.0013542385,0.00011066985,0.03654519],"genre_scores_gemma":[0.4182229,0.12767962,0.0087961275,0.39005044,0.016738176,0.00025378523,0.00326303,0.00022993813,0.034765974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955711,0.00072519283,0.0002954382,0.00027171033,0.0015637133,0.0015729567],"domain_scores_gemma":[0.98064846,0.004274673,0.0013945022,0.00022302651,0.004613843,0.008845583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038351566,0.00085472787,0.0011703494,0.0023604555,0.003157129,0.008043248,0.0026506355,0.010048061,0.044403262],"category_scores_gemma":[0.01759819,0.0005708354,0.0014951263,0.004380161,0.0029131186,0.0039120503,0.0018026179,0.008360948,0.0013033467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018376941,0.0008381854,0.027239395,0.001818639,0.00033061704,0.0017215515,0.00052035856,0.002500723,0.00065132556,0.021053512,0.58068806,0.3608],"study_design_scores_gemma":[0.0045617106,0.0007130502,0.17494588,0.011522488,0.0015329903,0.0018944982,0.0061878096,0.007098389,0.00081105664,0.027711134,0.76247084,0.0005502227],"about_ca_topic_score_codex":0.883685,"about_ca_topic_score_gemma":0.9487828,"teacher_disagreement_score":0.11631501,"about_ca_system_score_codex":0.041318692,"about_ca_system_score_gemma":0.1607014,"threshold_uncertainty_score":0.2997895},"labels":[],"label_agreement":null},{"id":"W4237991971","doi":"10.1007/bf03276098","title":"Outpatient treatment with LMWHs cost saving for DVT in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Business; Nursing","score_opus":0.034300354717029795,"score_gpt":0.33486820175065674,"score_spread":0.30056784703362693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237991971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9162318,0.01138161,0.00016793872,0.029846285,0.00035488128,0.0002524061,0.008516364,0.000049165224,0.03319951],"genre_scores_gemma":[0.9798537,0.006790202,0.00036650433,0.004166324,0.00032335462,0.000041409996,0.0022202537,0.000020643432,0.006217642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922824,0.00013141721,0.00005070307,0.000040212843,0.00029568112,0.00025372484],"domain_scores_gemma":[0.99530435,0.0006170479,0.0007114088,0.00005217127,0.0014586466,0.0018564103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042397509,0.00017847285,0.00041959612,0.00068418763,0.0011074075,0.00127919,0.0008070444,0.00074744824,0.0064798277],"category_scores_gemma":[0.006087845,0.00022065622,0.0005346959,0.0021375266,0.0003358755,0.00036287503,0.0003496542,0.0014763317,0.00014243294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053338367,0.0010315347,0.7576268,0.0008955879,0.0007051059,0.0014516116,0.00061976875,0.002251861,0.0007254632,0.002277911,0.07861909,0.14846146],"study_design_scores_gemma":[0.001013529,0.0005143641,0.97935474,0.00036655882,0.00040611587,0.00039034706,0.0012665356,0.0013690826,0.00018957077,0.0001982103,0.014896534,0.00003449582],"about_ca_topic_score_codex":0.98251903,"about_ca_topic_score_gemma":0.9936094,"teacher_disagreement_score":0.030296976,"about_ca_system_score_codex":0.030296976,"about_ca_system_score_gemma":0.048023194,"threshold_uncertainty_score":0.21982098},"labels":[],"label_agreement":null},{"id":"W4238317182","doi":"10.1007/bf03269190","title":"Which TB screening method for immigrants to Canada?","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immigration; Quality of Life Research; Public health; Political science; Medicine; Law; Nursing","score_opus":0.05501685564534359,"score_gpt":0.4369387218149321,"score_spread":0.3819218661695885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238317182","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009077251,0.02105226,0.00010271634,0.9461799,0.009809052,0.000036011155,0.00065044896,0.00004470562,0.013047634],"genre_scores_gemma":[0.16249019,0.07132311,0.0017380209,0.70653975,0.0250173,0.0001444795,0.0011922129,0.00015806015,0.031396776],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99794966,0.0002605347,0.00017739275,0.00014583528,0.0006607524,0.00080590486],"domain_scores_gemma":[0.9804616,0.0032007233,0.0011991895,0.00019677801,0.006494957,0.008446819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002804856,0.0004797591,0.0008043208,0.0019389866,0.006444999,0.0049383533,0.0019186293,0.0077830884,0.018765591],"category_scores_gemma":[0.021132873,0.00046047202,0.0012854413,0.0025592064,0.002320112,0.002488883,0.0009551529,0.012168325,0.0014739085],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004983741,0.00027556816,0.039745227,0.0007495997,0.0001270291,0.0006568213,0.0009338799,0.00011308842,0.0002333895,0.0014758565,0.81286156,0.1423296],"study_design_scores_gemma":[0.0012919239,0.0003697321,0.19947095,0.01225752,0.0015158667,0.0011838345,0.02795426,0.0008196323,0.0009921488,0.0046757683,0.74905545,0.00041305638],"about_ca_topic_score_codex":0.9483259,"about_ca_topic_score_gemma":0.9812243,"teacher_disagreement_score":0.051674128,"about_ca_system_score_codex":0.030968217,"about_ca_system_score_gemma":0.10392756,"threshold_uncertainty_score":0.22469121},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4238438364","doi":"10.1007/bf03276740","title":"Pharmaceutical sales rise by 14% in Canada, China","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; China; Business; Public health; Political science; Medicine; Law","score_opus":0.03730183461446839,"score_gpt":0.3188371479028117,"score_spread":0.2815353132883433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238438364","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81217283,0.009787101,0.00044343353,0.0648082,0.0010590209,0.0001154809,0.048202306,0.0008431756,0.062568456],"genre_scores_gemma":[0.9113781,0.0037165675,0.00047362424,0.005038241,0.00029254876,0.000018283234,0.010494218,0.000055366076,0.06853308],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927276,0.000021126685,0.000030133619,0.00005386786,0.00031729904,0.00030479912],"domain_scores_gemma":[0.9986338,0.00005505026,0.00018062943,0.000025778025,0.00068711874,0.00041763112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042858845,0.00040272184,0.000363382,0.0022924521,0.0019625048,0.0028862897,0.00062462746,0.0015232967,0.0066255503],"category_scores_gemma":[0.0015287115,0.0002859372,0.00081536366,0.004443114,0.0007258187,0.0006419714,0.0006134476,0.0012392334,0.0007700983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001053192,0.00020362221,0.6346445,0.00044092958,0.0003520201,0.002640802,0.0012100935,0.0024271063,0.002493665,0.007077455,0.26384076,0.08361579],"study_design_scores_gemma":[0.00005138301,0.00004164974,0.9362207,0.00002772056,0.00006455897,0.00013845881,0.0009231348,0.0011914031,0.0006007941,0.00020288273,0.060508315,0.000029044388],"about_ca_topic_score_codex":0.986568,"about_ca_topic_score_gemma":0.9925613,"teacher_disagreement_score":0.026220756,"about_ca_system_score_codex":0.026220756,"about_ca_system_score_gemma":0.053258818,"threshold_uncertainty_score":0.19024575},"labels":[],"label_agreement":null},{"id":"W4238548979","doi":"10.1007/s40274-021-7747-3","title":"Ribociclib + NSAI may be cost effective for advanced breast cancer in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Breast cancer; Cancer; Medicine; Public health; Internal medicine","score_opus":0.015470597123697947,"score_gpt":0.3594825584680343,"score_spread":0.3440119613443363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238548979","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19804566,0.05562014,0.000649185,0.55053526,0.0043662013,0.000350198,0.023216961,0.0004939502,0.1667225],"genre_scores_gemma":[0.7919285,0.060022477,0.0020077121,0.069285505,0.0032741032,0.00012554415,0.011685496,0.00014497248,0.061525777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994572,0.000056159493,0.000032673488,0.0000341508,0.00021717187,0.00020264606],"domain_scores_gemma":[0.99751806,0.0002607583,0.00019120122,0.00002185698,0.0008903792,0.0011177579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004399463,0.00018163201,0.00028204886,0.0005245046,0.0007541397,0.0015416405,0.00060623366,0.0007642658,0.01669674],"category_scores_gemma":[0.0033624216,0.0001488568,0.00072531676,0.001142265,0.00047802468,0.0003933483,0.00031437923,0.0015521419,0.0006122578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031653328,0.0003178361,0.046944372,0.0009066586,0.00033984397,0.0006295201,0.00014628946,0.0028389785,0.0011456376,0.006735595,0.64076793,0.29606193],"study_design_scores_gemma":[0.004180904,0.00096994924,0.29247072,0.0016052412,0.0011441838,0.0007226869,0.0011599986,0.0059332675,0.0012343068,0.0037385514,0.6867003,0.00013995248],"about_ca_topic_score_codex":0.9594494,"about_ca_topic_score_gemma":0.9869441,"teacher_disagreement_score":0.04055059,"about_ca_system_score_codex":0.036703058,"about_ca_system_score_gemma":0.061861593,"threshold_uncertainty_score":0.26630056},"labels":[],"label_agreement":null},{"id":"W4238611738","doi":"10.1007/bf03269365","title":"Formulary listing times drop in 4 Canadian provinces","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Listing (finance); Quality of Life Research; Business; Medicine; Public health; Finance; Family medicine","score_opus":0.048418104041826705,"score_gpt":0.3334772051408186,"score_spread":0.28505910109899185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238611738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.883413,0.0026785792,0.00021649447,0.02398406,0.00038150206,0.00009730126,0.027356528,0.00026045673,0.061611958],"genre_scores_gemma":[0.9559262,0.0011316043,0.00023759562,0.0025368803,0.00008435036,0.00002034985,0.0063698324,0.000069620146,0.033623546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972115,0.0000918951,0.00011314442,0.00016809952,0.0012451229,0.0011702274],"domain_scores_gemma":[0.98861045,0.0009281892,0.0018507747,0.00022402569,0.0059565757,0.0024299861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012916593,0.00026336836,0.0005362199,0.0032972249,0.003968221,0.0042145513,0.0014665045,0.0014124318,0.01062395],"category_scores_gemma":[0.009937728,0.0004213547,0.000646203,0.0070391158,0.00087504566,0.0007972437,0.00095597963,0.0014219654,0.00070710405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019890903,0.00023265935,0.6395209,0.00041047807,0.0002567539,0.0015897373,0.0045671724,0.0044811335,0.001417352,0.01298623,0.2562994,0.0762492],"study_design_scores_gemma":[0.000060681275,0.000036374007,0.9469108,0.00005054545,0.00004679963,0.00013383529,0.0040075756,0.0019529279,0.00041476512,0.00023774973,0.046091706,0.000056117206],"about_ca_topic_score_codex":0.9962857,"about_ca_topic_score_gemma":0.9978212,"teacher_disagreement_score":0.07925177,"about_ca_system_score_codex":0.07925177,"about_ca_system_score_gemma":0.08444967,"threshold_uncertainty_score":0.5750146},"labels":[],"label_agreement":null},{"id":"W4238629410","doi":"10.1007/s40274-014-1539-y","title":"Salmeterol/fluticasone cost effective in asthma in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Salmeterol; Fluticasone; Asthma; Quality of Life Research; Medicine; Public health; Internal medicine","score_opus":0.009858979572449989,"score_gpt":0.304686657059757,"score_spread":0.29482767748730704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238629410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55260736,0.07026292,0.00046702492,0.2517447,0.0034907258,0.0004440555,0.028903821,0.00027178056,0.09180763],"genre_scores_gemma":[0.9388841,0.024524122,0.0010121589,0.014825043,0.00132752,0.000056928864,0.0049127075,0.00006521712,0.01439215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788886,0.0001567099,0.00013278011,0.000112531576,0.0011113165,0.00059788924],"domain_scores_gemma":[0.99170893,0.00075252395,0.000559336,0.000069271526,0.0032534637,0.0036564886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093891594,0.0002406041,0.00054939254,0.0013256371,0.0012882352,0.0021522965,0.0012466747,0.0012241238,0.008808694],"category_scores_gemma":[0.0062058633,0.0003677396,0.0008547096,0.0025889913,0.00079581863,0.00065270736,0.0006111617,0.0018499979,0.00026780408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059274067,0.00086400367,0.26503956,0.0025033988,0.0008050555,0.0011627278,0.0005977526,0.0054777768,0.0013653131,0.008983403,0.38063857,0.32663503],"study_design_scores_gemma":[0.0024274045,0.0005541231,0.8832492,0.0013250359,0.0009602186,0.00038203347,0.0016465306,0.0059713577,0.0005977579,0.0009886036,0.10177089,0.00012683477],"about_ca_topic_score_codex":0.9926528,"about_ca_topic_score_gemma":0.9967265,"teacher_disagreement_score":0.07530488,"about_ca_system_score_codex":0.07530488,"about_ca_system_score_gemma":0.15185037,"threshold_uncertainty_score":0.5463777},"labels":[],"label_agreement":null},{"id":"W4238875952","doi":"10.1007/bf03276349","title":"Antibacterial use for outpatient CAP in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine; Nursing","score_opus":0.029828141058106942,"score_gpt":0.32263305937819003,"score_spread":0.2928049183200831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238875952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93652016,0.008259769,0.00014222176,0.019484073,0.00039376318,0.000104024584,0.0072691613,0.000060903916,0.027765902],"genre_scores_gemma":[0.9916397,0.0025695967,0.00013439932,0.0021036686,0.00014735083,0.000015400432,0.0012792923,0.000015159066,0.0020955894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991629,0.000060726958,0.000054460164,0.00006014696,0.0002834742,0.0003783549],"domain_scores_gemma":[0.99653196,0.00021860261,0.00062454207,0.000024111449,0.0010552655,0.0015455738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022834311,0.00018349076,0.00038944976,0.0008423533,0.0019399715,0.0014747201,0.00096240826,0.00085318956,0.0058636954],"category_scores_gemma":[0.0031621289,0.00026059532,0.00056579936,0.0022089363,0.00036543407,0.00035139572,0.00053891994,0.0016053221,0.0001732178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040734874,0.00021778619,0.95022345,0.00019259803,0.00010834992,0.0012357865,0.00050001504,0.0003746963,0.00030215722,0.0004826741,0.021418652,0.024536498],"study_design_scores_gemma":[0.000060351784,0.000069996204,0.992937,0.00013846053,0.000057452853,0.00039542315,0.0013447568,0.0005858504,0.000073680014,0.00006112501,0.0042598764,0.000015925169],"about_ca_topic_score_codex":0.9869196,"about_ca_topic_score_gemma":0.9954171,"teacher_disagreement_score":0.032162886,"about_ca_system_score_codex":0.032162886,"about_ca_system_score_gemma":0.04607358,"threshold_uncertainty_score":0.23335922},"labels":[],"label_agreement":null},{"id":"W4239074657","doi":"10.1007/s40274-013-0260-6","title":"Insulin pump program funded in Alberta, Canada","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.020822101581167533,"score_gpt":0.33711628342389505,"score_spread":0.3162941818427275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239074657","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19663733,0.015708322,0.0017134397,0.1569666,0.009980828,0.0015742333,0.038048167,0.00113008,0.57824105],"genre_scores_gemma":[0.27624816,0.0082298955,0.003872122,0.022845794,0.0011306738,0.000342237,0.011291695,0.00021419219,0.6758253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986141,0.00011206963,0.000023554467,0.000084406674,0.000609403,0.0005564607],"domain_scores_gemma":[0.99508435,0.00027075387,0.00012420202,0.00006256436,0.0012937929,0.0031643184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091754075,0.00037496517,0.00031343533,0.0008130826,0.0027100474,0.002278525,0.0012381409,0.0014276467,0.033450983],"category_scores_gemma":[0.0021080521,0.0003504162,0.00036986172,0.0010969181,0.0007405899,0.0003458826,0.0009903489,0.0018487102,0.0017068922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023787012,0.0008140641,0.048864093,0.0003598942,0.00012612806,0.0015068692,0.00026000247,0.0009387923,0.001948972,0.01209256,0.77894163,0.15176834],"study_design_scores_gemma":[0.002152458,0.0005514193,0.373353,0.00048785997,0.00015280004,0.0007135161,0.001595787,0.0027127047,0.0011833046,0.0010936771,0.61593145,0.000072097006],"about_ca_topic_score_codex":0.9631802,"about_ca_topic_score_gemma":0.98769253,"teacher_disagreement_score":0.038949773,"about_ca_system_score_codex":0.038949773,"about_ca_system_score_gemma":0.18164304,"threshold_uncertainty_score":0.2826017},"labels":[],"label_agreement":null},{"id":"W4239255913","doi":"10.1007/bf03279550","title":"Methylphenidate use low but rising among children in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methylphenidate; Quality of Life Research; Psychology; Public health; Medicine; Psychiatry; Attention deficit hyperactivity disorder","score_opus":0.03755825418251017,"score_gpt":0.3154979730792761,"score_spread":0.2779397188967659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239255913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475687,0.005453312,0.00010533887,0.023438204,0.0002828105,0.00003232369,0.011091075,0.00005706256,0.011971114],"genre_scores_gemma":[0.98979586,0.0032817707,0.00026176512,0.0019451778,0.000079319165,0.000013722039,0.0021116314,0.000020156496,0.0024906145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900395,0.000040395054,0.000064983724,0.00008930416,0.00043516335,0.00036623483],"domain_scores_gemma":[0.99618965,0.00020653752,0.00060767605,0.00004031677,0.0017452718,0.0012105831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027675094,0.00020240678,0.00043044097,0.001166514,0.0020350863,0.0013031021,0.0010902088,0.0010265089,0.0021251352],"category_scores_gemma":[0.002178359,0.00031542036,0.00050263724,0.004047291,0.00057497714,0.0005550539,0.00051459495,0.0020109173,0.00015624495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000458752,0.000031130927,0.9796348,0.000053631702,0.000029510618,0.00029539806,0.00045085844,0.00006494222,0.00020960967,0.00015517382,0.010802064,0.008226991],"study_design_scores_gemma":[0.0000047461785,0.000009859317,0.9966453,0.000040149844,0.000022393666,0.00010424211,0.0011050234,0.00007740346,0.00006580879,0.000019083898,0.0018986689,0.0000073660144],"about_ca_topic_score_codex":0.9918181,"about_ca_topic_score_gemma":0.9970927,"teacher_disagreement_score":0.021384593,"about_ca_system_score_codex":0.021384593,"about_ca_system_score_gemma":0.036476675,"threshold_uncertainty_score":0.15515685},"labels":[],"label_agreement":null},{"id":"W4239369968","doi":"10.1007/s40274-021-7452-2","title":"Early-phase trials used in reimbursement submissions in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Quality of Life Research; Phase (matter); Actuarial science; Business; Medicine; Public health; Political science; Chemistry; Nursing; Law; Health care","score_opus":0.4574671061897916,"score_gpt":0.5305500618397155,"score_spread":0.07308295564992395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239369968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24606694,0.18899378,0.014239783,0.18574955,0.03714908,0.028900852,0.09482769,0.0026047386,0.20146763],"genre_scores_gemma":[0.81484395,0.035928547,0.02605775,0.05174527,0.0049623265,0.005741191,0.023639077,0.0009790532,0.036102794],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9187091,0.037143193,0.0102632735,0.0038974055,0.023990309,0.005996651],"domain_scores_gemma":[0.60474294,0.14151515,0.025637787,0.014551915,0.17530467,0.038247526],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08981873,0.00083679333,0.002727032,0.0038876957,0.003912898,0.0121456655,0.0029473298,0.0036456457,0.01129623],"category_scores_gemma":[0.27092996,0.0012396271,0.0024465339,0.006576185,0.0023581008,0.0020131443,0.0022192905,0.005028521,0.0018246588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034277882,0.0010687063,0.038988594,0.0093346415,0.0019714856,0.00061727257,0.0016081446,0.0041987016,0.0012605155,0.011093578,0.50599146,0.3895889],"study_design_scores_gemma":[0.02835302,0.006554219,0.26811475,0.015580542,0.0031316553,0.0004666982,0.0016450244,0.004975708,0.0031766198,0.005895443,0.66139966,0.00070669473],"about_ca_topic_score_codex":0.77396107,"about_ca_topic_score_gemma":0.8459533,"teacher_disagreement_score":0.93470645,"about_ca_system_score_codex":0.06529352,"about_ca_system_score_gemma":0.17408755,"threshold_uncertainty_score":0.47501254},"labels":[],"label_agreement":null},{"id":"W4239490125","doi":"10.2165/00151234-200805520-00015","title":"COPD exacerbations exasperate costs in Canada","year":2008,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; COPD; Health economics; Medicine; Public health; Business; Nursing; Internal medicine","score_opus":0.027976318476197814,"score_gpt":0.3277751043964014,"score_spread":0.2997987859202036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239490125","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.118913926,0.01970321,0.0002022543,0.7823066,0.008064356,0.000078055295,0.012813646,0.00018263512,0.0577354],"genre_scores_gemma":[0.79272175,0.022758413,0.00066413335,0.11172566,0.0070431726,0.00006244506,0.0052535045,0.00015293258,0.059617914],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976179,0.000114356815,0.0001350754,0.000089408815,0.0012101264,0.0008329814],"domain_scores_gemma":[0.98462206,0.0010753614,0.0011732569,0.00016660772,0.0055727144,0.007389973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093755045,0.00030871574,0.00046521286,0.0015657411,0.0026659628,0.0043157656,0.0012464402,0.0036379357,0.010200597],"category_scores_gemma":[0.011252536,0.00046563408,0.00093073235,0.0025690603,0.0008169868,0.0012100823,0.0011613623,0.004192846,0.00051774306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005949251,0.00013614626,0.11399584,0.000348863,0.00020127332,0.0005398856,0.0005589116,0.00073240435,0.00024176073,0.004444522,0.79555714,0.082648374],"study_design_scores_gemma":[0.00045769915,0.00012986526,0.65458494,0.00081131555,0.00035940282,0.0003878377,0.0030967821,0.002344004,0.00041194854,0.0019559383,0.33531,0.00015027814],"about_ca_topic_score_codex":0.98834383,"about_ca_topic_score_gemma":0.9962824,"teacher_disagreement_score":0.06884376,"about_ca_system_score_codex":0.06884376,"about_ca_system_score_gemma":0.1339601,"threshold_uncertainty_score":0.49949878},"labels":[],"label_agreement":null},{"id":"W4239596802","doi":"10.1007/s40274-013-0638-5","title":"A quarter of US antibiotic prescriptions are not indicated","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medical prescription; Quality of Life Research; Antibiotics; Health economics; Public health; Medicine; Pharmacology; Microbiology; History; Nursing; Biology","score_opus":0.014088377768994423,"score_gpt":0.27487949035444886,"score_spread":0.26079111258545445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239596802","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14740367,0.047701612,0.00082771975,0.47061706,0.057388358,0.000085204396,0.03765523,0.0015051293,0.2368161],"genre_scores_gemma":[0.38523126,0.047256358,0.0013069822,0.26361114,0.017397204,0.00012997027,0.02328055,0.00030620146,0.26148033],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9992685,0.00009304456,0.000067287096,0.00006350027,0.00034136517,0.00016630546],"domain_scores_gemma":[0.9970209,0.0005691959,0.000817934,0.00013224411,0.00063052174,0.00082915823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004518707,0.00028723228,0.00029005023,0.0006440314,0.00046036558,0.0009460728,0.0003160498,0.001781479,0.027703742],"category_scores_gemma":[0.003546421,0.00018103758,0.00042864666,0.0011721184,0.00025112956,0.0005839254,0.000424121,0.0018772171,0.008638333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002635561,0.00012669919,0.02600527,0.00018303432,0.000028134617,0.00030828244,0.00006119759,0.000042757005,0.0010593461,0.0006866802,0.8787128,0.09252222],"study_design_scores_gemma":[0.0000957681,0.00011906639,0.16058476,0.00034663218,0.000055439115,0.0007360846,0.00050990685,0.0002136609,0.00095177826,0.00053120265,0.8358287,0.000026878159],"about_ca_topic_score_codex":0.013933818,"about_ca_topic_score_gemma":0.022046287,"teacher_disagreement_score":0.027703742,"about_ca_system_score_codex":0.0006234281,"about_ca_system_score_gemma":0.0020529472,"threshold_uncertainty_score":0.09267819},"labels":[],"label_agreement":null},{"id":"W4239998127","doi":"10.1007/s40274-018-4899-x","title":"Cost of living kidney donor care substantial in Canada","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Public health; Business; Medicine; Environmental health; Nursing","score_opus":0.02206480715044049,"score_gpt":0.32596959214293003,"score_spread":0.3039047849924895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239998127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49505466,0.027368587,0.00052487105,0.3779645,0.0031547241,0.00010598486,0.018996088,0.0001751312,0.07665556],"genre_scores_gemma":[0.9345647,0.017807318,0.0006723011,0.018853288,0.00069131434,0.000025640813,0.0035954062,0.00006687878,0.023723193],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983767,0.0001037321,0.00007423693,0.00008057942,0.000706671,0.0006579775],"domain_scores_gemma":[0.99287933,0.0004641962,0.000555053,0.00007069249,0.0021661734,0.003864589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005332322,0.00025690673,0.00043639055,0.0011318006,0.0026059279,0.0034418013,0.0010618985,0.0014228623,0.009662502],"category_scores_gemma":[0.004780918,0.00035892564,0.0007229242,0.003014641,0.0010429075,0.0007850545,0.001113776,0.0028863146,0.00023543282],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079640443,0.00026153904,0.3839161,0.00097338407,0.000616763,0.00272482,0.0011673827,0.0033818616,0.0008489574,0.027416307,0.45507127,0.12282521],"study_design_scores_gemma":[0.00033887863,0.00010652048,0.7826962,0.0010417243,0.00044874224,0.0011638887,0.005238838,0.0034700972,0.000516292,0.0030068199,0.201799,0.00017298112],"about_ca_topic_score_codex":0.99547714,"about_ca_topic_score_gemma":0.99825436,"teacher_disagreement_score":0.0946417,"about_ca_system_score_codex":0.0946417,"about_ca_system_score_gemma":0.18891764,"threshold_uncertainty_score":0.6866768},"labels":[],"label_agreement":null},{"id":"W4240222421","doi":"10.1007/s40274-017-4497-3","title":"Costs of AMI high in Canada but decreasing","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Public health; Nursing","score_opus":0.05276754108564626,"score_gpt":0.3283007964239006,"score_spread":0.27553325533825435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240222421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65880114,0.023350272,0.00068477454,0.23712726,0.0009705896,0.000075516204,0.035517965,0.00012710305,0.04334531],"genre_scores_gemma":[0.9744324,0.0054733725,0.00056150794,0.006079788,0.00037705232,0.000012779307,0.0066548935,0.000033728284,0.006374496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986228,0.0001028561,0.000089390545,0.00009818145,0.00041116847,0.00067559554],"domain_scores_gemma":[0.99167866,0.0005499894,0.0015852782,0.00013537004,0.0029913827,0.0030592799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060505583,0.00032458745,0.00052190135,0.0011598074,0.0018245861,0.0027393964,0.001175724,0.001833503,0.0072415653],"category_scores_gemma":[0.006778558,0.00036409753,0.0010339086,0.0033219117,0.0008016064,0.0009149279,0.00077235635,0.00377598,0.00024430687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000908361,0.00019196954,0.81009686,0.00035624646,0.00061267545,0.00096357136,0.00045177658,0.0039838688,0.00041083785,0.012239774,0.12451065,0.045273434],"study_design_scores_gemma":[0.00008934908,0.00003677122,0.97675246,0.00020511745,0.00025029766,0.00038152476,0.0011512873,0.0022556637,0.00012140735,0.0018293326,0.01687094,0.00005576045],"about_ca_topic_score_codex":0.99380577,"about_ca_topic_score_gemma":0.99710923,"teacher_disagreement_score":0.054171056,"about_ca_system_score_codex":0.054171056,"about_ca_system_score_gemma":0.067595124,"threshold_uncertainty_score":0.39304036},"labels":[],"label_agreement":null},{"id":"W4240472339","doi":"10.2165/00151234-200805570-00031","title":"Quebec has become the first Canadian province to reimburse the rivastigmine [Exelon] transdermal patch,","year":2008,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivastigmine; Business; Transdermal patch; Quality of Life Research; Medicine; Pharmacology; Public health; Transdermal; Nursing; Internal medicine","score_opus":0.14346386070170758,"score_gpt":0.3752627988071266,"score_spread":0.23179893810541902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240472339","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094800465,0.028477198,0.006040959,0.18526062,0.0071407324,0.0008830826,0.0143311545,0.0017111015,0.66135466],"genre_scores_gemma":[0.24043044,0.008118745,0.008292574,0.03578469,0.0004400322,0.00012600727,0.0042743953,0.00025717754,0.70227593],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892527,0.00008845986,0.000025016676,0.00007106797,0.0006576516,0.0002325252],"domain_scores_gemma":[0.9967753,0.00026814858,0.00013718278,0.00006137552,0.0020048,0.0007532525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011652769,0.0002631633,0.00028037772,0.00066124287,0.002348394,0.0017975107,0.0007937563,0.0018070303,0.030301573],"category_scores_gemma":[0.0023311335,0.00018814333,0.00044504914,0.0005797968,0.00069692836,0.0004247793,0.00036019806,0.0014037336,0.0024905067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005943685,0.00016960109,0.01924666,0.00032353736,0.00009271437,0.00068702694,0.00016117282,0.00067844416,0.0058587315,0.013856729,0.79114574,0.16718516],"study_design_scores_gemma":[0.00011285307,0.00012916293,0.02080473,0.0000975597,0.000035062523,0.00032981177,0.0001900697,0.0005366718,0.0011644004,0.00025369454,0.97631854,0.000027395094],"about_ca_topic_score_codex":0.9567667,"about_ca_topic_score_gemma":0.98227316,"teacher_disagreement_score":0.043233275,"about_ca_system_score_codex":0.022065578,"about_ca_system_score_gemma":0.06422213,"threshold_uncertainty_score":0.16009772},"labels":[],"label_agreement":null},{"id":"W4241293564","doi":"10.1007/bf03280638","title":"Canadian government and Shire agree on 'flu vaccines","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Shire; Government (linguistics); Quality of Life Research; Virology; Public health; Public administration; Medicine; Political science; Geography; Archaeology; Philosophy","score_opus":0.02137698621031893,"score_gpt":0.32764423620432853,"score_spread":0.3062672499940096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241293564","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015182312,0.0014124376,0.00009517571,0.9157588,0.021914398,0.00003399911,0.0005987997,0.00010576426,0.058562305],"genre_scores_gemma":[0.012595387,0.0010180916,0.0002103178,0.7996876,0.0061199344,0.00003359361,0.00033128317,0.00006282754,0.17994095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881712,0.00040991374,0.0003662714,0.00051637844,0.0067327414,0.0038035456],"domain_scores_gemma":[0.9808203,0.005202067,0.0007310521,0.00070154073,0.008065983,0.004479166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004835645,0.0008250673,0.001441192,0.0013885432,0.01122019,0.0089982785,0.0021414775,0.050091255,0.04005984],"category_scores_gemma":[0.027711257,0.0007062915,0.0018864125,0.0017019802,0.0039338334,0.002692544,0.0023116078,0.02676275,0.010108683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034731802,0.000016209067,0.00036266306,0.000012776006,0.000010574372,0.00007845593,0.00010770513,0.000016578015,0.00004325213,0.004676274,0.99147815,0.0031627542],"study_design_scores_gemma":[0.000064993474,0.000018129838,0.004570608,0.00006528139,0.000029486768,0.000041845884,0.000644339,0.00004544165,0.00009586524,0.0017446749,0.9926299,0.000049433063],"about_ca_topic_score_codex":0.7946772,"about_ca_topic_score_gemma":0.89881635,"teacher_disagreement_score":0.2053228,"about_ca_system_score_codex":0.016227039,"about_ca_system_score_gemma":0.052822445,"threshold_uncertainty_score":0.41306394},"labels":[],"label_agreement":null},{"id":"W4241570227","doi":"10.2165/00151234-201206580-00017","title":"Intrathecal analgesics worth it for chronic pain in Canada","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Intrathecal; Chronic pain; Medicine; Pain management; Anesthesia; Public health; Physical therapy; Nursing","score_opus":0.023261385635946593,"score_gpt":0.3230461119529087,"score_spread":0.2997847263169621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241570227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4737743,0.040778376,0.00040123923,0.37172404,0.0029097365,0.00019110844,0.009159574,0.00014587957,0.10091583],"genre_scores_gemma":[0.8816036,0.032274455,0.0007468808,0.041811742,0.0014148005,0.00004027458,0.0017737799,0.00007579897,0.040258694],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9993426,0.000027493477,0.00003372216,0.000030887877,0.0003260676,0.0002391644],"domain_scores_gemma":[0.9954164,0.0003256053,0.00047368446,0.000030038233,0.0015164085,0.0022378173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030382499,0.00013566042,0.00022577385,0.0008316114,0.002324562,0.0015226093,0.00070994237,0.0012116279,0.008020191],"category_scores_gemma":[0.0026927923,0.00023634573,0.0003150414,0.002054591,0.00078469364,0.00045008727,0.00042773742,0.0023340075,0.00026393848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001368715,0.0005133621,0.27591068,0.00096131925,0.00022985208,0.00301372,0.0014632388,0.00070748606,0.0019026228,0.0074635684,0.49691877,0.20954669],"study_design_scores_gemma":[0.0005823261,0.0002677093,0.7339453,0.0008843158,0.00027687286,0.0014572688,0.0044413065,0.0013379067,0.00071899506,0.0007936737,0.25517875,0.0001155603],"about_ca_topic_score_codex":0.99054796,"about_ca_topic_score_gemma":0.9980248,"teacher_disagreement_score":0.036350448,"about_ca_system_score_codex":0.036350448,"about_ca_system_score_gemma":0.10661703,"threshold_uncertainty_score":0.26374215},"labels":[],"label_agreement":null},{"id":"W4242090716","doi":"10.1007/bf03275938","title":"IV PPI use warranted for GI haemorrhage in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health","score_opus":0.03915739238221776,"score_gpt":0.33871039163999234,"score_spread":0.29955299925777457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242090716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8427992,0.010884467,0.000303872,0.05745545,0.0009683517,0.00021413589,0.0074431463,0.00009008217,0.079841346],"genre_scores_gemma":[0.9856426,0.003004704,0.00029318925,0.0051546493,0.0002456526,0.000012498335,0.0011847459,0.000018324223,0.004443666],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923253,0.00005109389,0.000058103946,0.0000509958,0.00029033166,0.00031700678],"domain_scores_gemma":[0.99623066,0.000349747,0.00051266805,0.000028370694,0.0014425984,0.0014359879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023220081,0.00019074552,0.00038522942,0.001009508,0.0019482056,0.0011742148,0.0009162246,0.0014057906,0.0050973417],"category_scores_gemma":[0.0050429995,0.00024024329,0.00038160844,0.0024639762,0.00046470517,0.0003078405,0.00039789866,0.0021104668,0.00021570454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011056432,0.00020576792,0.8881177,0.00034539527,0.00014210062,0.014177265,0.0008218536,0.0006274783,0.0006326799,0.0016057653,0.048448376,0.043770015],"study_design_scores_gemma":[0.00028871154,0.0002765099,0.9598637,0.00040724617,0.0002922488,0.005337279,0.005156703,0.0018905343,0.0004594541,0.00053486566,0.025415394,0.00007731824],"about_ca_topic_score_codex":0.9816783,"about_ca_topic_score_gemma":0.9930419,"teacher_disagreement_score":0.025778588,"about_ca_system_score_codex":0.025778588,"about_ca_system_score_gemma":0.058254078,"threshold_uncertainty_score":0.18703765},"labels":[],"label_agreement":null},{"id":"W4242511439","doi":"10.1007/bf03280586","title":"Newer neuropsychotherapeutic agents increase expenditure in Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Economics; Public health; Medicine; Nursing","score_opus":0.2345095394759057,"score_gpt":0.4527698876803418,"score_spread":0.21826034820443613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242511439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78501225,0.018935345,0.0003179323,0.09783983,0.00089936145,0.0001454303,0.032598708,0.00017734506,0.06407373],"genre_scores_gemma":[0.9565689,0.010592098,0.00036191288,0.006515349,0.000373924,0.000029022018,0.004864781,0.00005038735,0.020643631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885833,0.00009018735,0.00006701305,0.00005696051,0.00052943046,0.0003980634],"domain_scores_gemma":[0.9946477,0.00047181005,0.00075333077,0.000056427703,0.0024467881,0.0016239334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050603505,0.00026727302,0.000443293,0.0017864181,0.001481812,0.0016134637,0.000924634,0.0010400842,0.009126456],"category_scores_gemma":[0.004796426,0.0003185254,0.0008577405,0.0033620815,0.00050785724,0.00043106842,0.0005584823,0.0015046613,0.00032842046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018866945,0.00037696157,0.6751058,0.0006334291,0.00044941463,0.0009596985,0.00054473773,0.002867279,0.0006550851,0.004627401,0.20196095,0.109932564],"study_design_scores_gemma":[0.00024298773,0.000110005836,0.9619408,0.00019777837,0.00024719583,0.00024447584,0.0008178702,0.002122001,0.00032024927,0.00030614872,0.033408638,0.00004189874],"about_ca_topic_score_codex":0.99637574,"about_ca_topic_score_gemma":0.9978802,"teacher_disagreement_score":0.06087637,"about_ca_system_score_codex":0.06087637,"about_ca_system_score_gemma":0.07608225,"threshold_uncertainty_score":0.44169104},"labels":[],"label_agreement":null},{"id":"W4242710605","doi":"10.1007/bf03278876","title":"Pioglitazone economically attractive for type 2 DM in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pioglitazone; Quality of Life Research; Public health; Type 2 diabetes; Medicine; Endocrinology","score_opus":0.04886457988781469,"score_gpt":0.3300135550347344,"score_spread":0.2811489751469197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242710605","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2687014,0.02290385,0.00047701222,0.47288692,0.003799829,0.00030309337,0.0076300525,0.0002131524,0.22308476],"genre_scores_gemma":[0.8445719,0.018886235,0.0011077336,0.047755238,0.0018397046,0.000074698844,0.0018345728,0.00007001084,0.08385985],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9992461,0.000043490098,0.000022569619,0.000030831805,0.0003807674,0.00027628348],"domain_scores_gemma":[0.9971512,0.0003339052,0.00014685937,0.000023622062,0.0006307762,0.0017138142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004869249,0.00015706233,0.0002782113,0.00091213774,0.0019078483,0.0025715076,0.0006630683,0.0018639686,0.012611344],"category_scores_gemma":[0.0027879262,0.0002068309,0.0004226483,0.0013133904,0.00055941974,0.00034229964,0.00042594917,0.0018327448,0.00038737143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032881186,0.000470631,0.088860065,0.0005860355,0.00018380131,0.002828377,0.0005069393,0.0024833966,0.002556107,0.031983923,0.65463436,0.21161821],"study_design_scores_gemma":[0.0020956004,0.00049426436,0.31655842,0.0005825132,0.00034654207,0.0009364385,0.0022370077,0.0036589035,0.0010406639,0.0038867746,0.6680402,0.00012264251],"about_ca_topic_score_codex":0.97087663,"about_ca_topic_score_gemma":0.99042225,"teacher_disagreement_score":0.029123366,"about_ca_system_score_codex":0.026020123,"about_ca_system_score_gemma":0.098836705,"threshold_uncertainty_score":0.18879008},"labels":[],"label_agreement":null},{"id":"W4243068281","doi":"10.2165/00151234-201106200-00034","title":"Azacitidine reimbursed in Quebec, Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Azacitidine; Public health; Medicine; Chemistry; Nursing","score_opus":0.02704849171701705,"score_gpt":0.29306961876654736,"score_spread":0.2660211270495303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243068281","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22302315,0.104069345,0.0005016195,0.354206,0.008078699,0.00028970191,0.050879315,0.00043971257,0.25851253],"genre_scores_gemma":[0.7425865,0.0409548,0.0009906507,0.042421248,0.0023020033,0.00010100069,0.010862627,0.0001066607,0.15967454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898916,0.00011208191,0.000055050423,0.00006822395,0.00047915446,0.0002963406],"domain_scores_gemma":[0.9958858,0.0003664878,0.00032280607,0.00005647952,0.001807075,0.0015614252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061155274,0.00015077113,0.00032221802,0.0007023859,0.0015905428,0.0019209199,0.0009195296,0.0015568392,0.018744482],"category_scores_gemma":[0.0031246138,0.0002041611,0.00040100882,0.0016539043,0.0005164436,0.00044884562,0.00030945506,0.0016811786,0.0008049135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012634841,0.00014578542,0.06815885,0.00065860926,0.00017581055,0.0012698962,0.00028843182,0.0011497934,0.0012060279,0.006924143,0.7828572,0.1359019],"study_design_scores_gemma":[0.00075725606,0.00015315597,0.43473816,0.0006642781,0.00018222218,0.0005112707,0.000630695,0.0016614312,0.0006584101,0.00038991318,0.5595771,0.00007608033],"about_ca_topic_score_codex":0.9894493,"about_ca_topic_score_gemma":0.9960031,"teacher_disagreement_score":0.046653602,"about_ca_system_score_codex":0.046653602,"about_ca_system_score_gemma":0.080105945,"threshold_uncertainty_score":0.33849716},"labels":[],"label_agreement":null},{"id":"W4243325939","doi":"10.2165/00151234-200404500-00044","title":"Medical association welcomes Canadian govt funding initiative","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Association (psychology); Public health; Library science; Political science; Medicine; Computer science; Nursing; Psychology","score_opus":0.0713932492317379,"score_gpt":0.40974690017593984,"score_spread":0.33835365094420194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243325939","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025014568,0.002639048,0.00039599597,0.50091994,0.04734308,0.00026614955,0.0056913323,0.0010627116,0.43918025],"genre_scores_gemma":[0.006849128,0.00083206705,0.0004990384,0.06456183,0.0034470053,0.00007750168,0.001531175,0.00021805146,0.9219842],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889563,0.0004057462,0.00017434158,0.00035284163,0.0077043413,0.0024065187],"domain_scores_gemma":[0.96563375,0.0031644895,0.0005395552,0.00079060957,0.014776145,0.015095438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059240307,0.0008696578,0.000900182,0.0031997766,0.008275213,0.012126594,0.0025251326,0.02843592,0.14465763],"category_scores_gemma":[0.022058876,0.00078591227,0.0012911685,0.0016291925,0.001792329,0.001743256,0.0035050502,0.010089135,0.043858845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021109812,0.000021221253,0.00014346596,0.000012045915,0.0000024818946,0.00004104109,0.00001257278,0.000010639753,0.000027492897,0.0027645126,0.99286944,0.004073999],"study_design_scores_gemma":[0.00006045338,0.000015720969,0.0015349574,0.000051174375,0.000008340382,0.000035821133,0.00008570985,0.000089235305,0.000065117936,0.0008741213,0.9971624,0.000016834287],"about_ca_topic_score_codex":0.6125632,"about_ca_topic_score_gemma":0.8333127,"teacher_disagreement_score":0.97305006,"about_ca_system_score_codex":0.026949923,"about_ca_system_score_gemma":0.1718158,"threshold_uncertainty_score":0.779437},"labels":[],"label_agreement":null},{"id":"W4243610834","doi":"10.1007/s40274-013-0885-5","title":"Economic impact of introducing dimethyl fumarate into Canada","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chemical Synthesis and Reactions","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dimethyl fumarate; Quality of Life Research; Chemistry; Public health; Medicine","score_opus":0.007919565342639892,"score_gpt":0.29460752684037295,"score_spread":0.28668796149773307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243610834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33246627,0.031055175,0.002134629,0.32045576,0.009469381,0.00047084806,0.014197463,0.0006176362,0.28913292],"genre_scores_gemma":[0.82849264,0.022247262,0.0016387735,0.028016264,0.0011263216,0.00006253688,0.0033965842,0.00009054732,0.11492915],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976472,0.00013977468,0.00005280364,0.00011588015,0.0013109578,0.0007333798],"domain_scores_gemma":[0.9965837,0.00046734884,0.0002009544,0.000060249706,0.0015471155,0.0011404679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012671008,0.0005156747,0.00032333875,0.001186822,0.0019299698,0.0027279956,0.0013087004,0.0030947644,0.010909029],"category_scores_gemma":[0.004480285,0.00031436933,0.0008407984,0.00096891617,0.001203212,0.0005801553,0.0010616315,0.002768516,0.00055750477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010082564,0.0009808817,0.032396324,0.0015133166,0.0005344336,0.0049737426,0.00056161184,0.014856252,0.03537883,0.09678096,0.53511477,0.2668263],"study_design_scores_gemma":[0.0010716586,0.0015970706,0.071078934,0.00041533343,0.00039994903,0.0006298589,0.0013215404,0.005211607,0.021600405,0.002950211,0.8935278,0.0001957424],"about_ca_topic_score_codex":0.9690713,"about_ca_topic_score_gemma":0.9670192,"teacher_disagreement_score":0.0532373,"about_ca_system_score_codex":0.0532373,"about_ca_system_score_gemma":0.118873835,"threshold_uncertainty_score":0.38626546},"labels":[],"label_agreement":null},{"id":"W4244148411","doi":"10.1007/s40274-013-0929-x","title":"Crizotinib effective but too costly in Canada and the US","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Crizotinib; Quality of Life Research; Public health; Medicine; Lung cancer; Oncology","score_opus":0.00763180274617116,"score_gpt":0.316984452600487,"score_spread":0.3093526498543159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244148411","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037547562,0.051816627,0.00019939279,0.85930365,0.0056012706,0.00003058053,0.0051535917,0.000101227524,0.040246084],"genre_scores_gemma":[0.4570338,0.084499985,0.0012859156,0.4142769,0.007561891,0.00004572726,0.0050451374,0.00026581404,0.029984878],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974655,0.00019321236,0.00014920926,0.00015412284,0.0013415676,0.0006964828],"domain_scores_gemma":[0.9904835,0.0011828532,0.0007620072,0.00010720448,0.003290495,0.004173797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017407608,0.0002970647,0.0006570647,0.0011203757,0.0017797651,0.0038250596,0.0010862506,0.0029954023,0.007723564],"category_scores_gemma":[0.009627299,0.00025788788,0.0007850956,0.0024738465,0.0016580777,0.0011625616,0.0006576884,0.006503028,0.0004250681],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017704795,0.000106628926,0.024024073,0.00042194844,0.00032383428,0.00080900453,0.0002737088,0.0007663874,0.0011691608,0.012183633,0.79427236,0.16387883],"study_design_scores_gemma":[0.0015092953,0.00034681082,0.18438642,0.002095773,0.0010338166,0.0009525254,0.0026210793,0.0013036064,0.0014477646,0.006532479,0.7975452,0.0002252023],"about_ca_topic_score_codex":0.9506721,"about_ca_topic_score_gemma":0.97549915,"teacher_disagreement_score":0.04932791,"about_ca_system_score_codex":0.041870084,"about_ca_system_score_gemma":0.08801962,"threshold_uncertainty_score":0.30379015},"labels":[],"label_agreement":null},{"id":"W4244536565","doi":"10.2165/00151234-200404610-00013","title":"Fibromyalgia exacts substantial costs in Canada","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Fibromyalgia; Health economics; Public health; Business; Economics; Psychology; Medicine; Psychiatry; Nursing","score_opus":0.3368159591054161,"score_gpt":0.5178121967040649,"score_spread":0.18099623759864875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244536565","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1338489,0.026666956,0.000356999,0.6799468,0.008806577,0.00011200721,0.009360986,0.00030422743,0.14059664],"genre_scores_gemma":[0.70654434,0.040372398,0.0011616955,0.10186084,0.005303354,0.000054757376,0.004914289,0.00019644485,0.13959181],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99789906,0.00008296733,0.00008641228,0.000069013484,0.0012804919,0.0005820798],"domain_scores_gemma":[0.99020714,0.0006288046,0.00064810447,0.00008980034,0.0039629927,0.004463255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068391644,0.00026968092,0.00037109788,0.001428426,0.0031863658,0.0032606295,0.00088996004,0.0030393333,0.015932387],"category_scores_gemma":[0.006988236,0.00040595882,0.0005741272,0.0025556667,0.0008839942,0.0008026272,0.0008603935,0.003331754,0.0008162258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033047577,0.00013161248,0.0679637,0.000362388,0.00010712343,0.0008061695,0.0004288851,0.0005158703,0.0002809739,0.004261988,0.81310457,0.11170627],"study_design_scores_gemma":[0.00029910365,0.0001499289,0.45308632,0.0007788549,0.00018948001,0.00061408087,0.0029636067,0.0013291171,0.0003103866,0.0014697694,0.53867096,0.0001384182],"about_ca_topic_score_codex":0.9909093,"about_ca_topic_score_gemma":0.9971432,"teacher_disagreement_score":0.05224998,"about_ca_system_score_codex":0.05224998,"about_ca_system_score_gemma":0.13764419,"threshold_uncertainty_score":0.37910193},"labels":[],"label_agreement":null},{"id":"W4244584981","doi":"10.1007/s40274-017-3697-1","title":"Quadrivalent ACWY vaccine not cost effective in Quebec","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Public health; Medicine; Nursing","score_opus":0.027992058155788483,"score_gpt":0.3950212222470871,"score_spread":0.3670291640912986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244584981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8170606,0.028436776,0.0008525922,0.062432606,0.0020136214,0.00041110892,0.019586956,0.00024410768,0.06896167],"genre_scores_gemma":[0.9680582,0.005478424,0.00085165026,0.0080794925,0.00024536863,0.00010043475,0.0028894923,0.00004052706,0.014256516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99922657,0.00021519697,0.000046639092,0.00006743427,0.00019652522,0.00024758533],"domain_scores_gemma":[0.99698657,0.00072843966,0.0003211067,0.00008038101,0.0010971834,0.0007862877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012532562,0.00017411748,0.00032101024,0.00036351645,0.0005133538,0.0009963523,0.00065571285,0.0006765901,0.009547407],"category_scores_gemma":[0.0038095973,0.0001297133,0.00042856045,0.00081303064,0.00035314323,0.0005358372,0.00022009878,0.00085968047,0.0002749877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013629911,0.0011235372,0.31610948,0.0014767076,0.0011545247,0.0018975482,0.00045476403,0.0075660674,0.0075767087,0.0082788365,0.2751,0.36563197],"study_design_scores_gemma":[0.003941963,0.003863743,0.8447881,0.001074369,0.0011547284,0.0006841751,0.0011093017,0.0064890725,0.0026901602,0.0007183252,0.13340352,0.00008263201],"about_ca_topic_score_codex":0.94938767,"about_ca_topic_score_gemma":0.97148705,"teacher_disagreement_score":0.05061233,"about_ca_system_score_codex":0.025373152,"about_ca_system_score_gemma":0.026481703,"threshold_uncertainty_score":0.18409598},"labels":[],"label_agreement":null},{"id":"W4244772948","doi":"10.1007/bf03275753","title":"Healthcare spending soars in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Business; Health economics; Economics; Public health; Nursing; Medicine; Economic growth","score_opus":0.06540893024274555,"score_gpt":0.33228857306526643,"score_spread":0.26687964282252086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244772948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61803806,0.012918237,0.00024640583,0.284059,0.0017966584,0.00008519631,0.027799543,0.00024968205,0.054807164],"genre_scores_gemma":[0.9541378,0.0043484177,0.00020315063,0.011967864,0.0005342117,0.00002352691,0.004274898,0.00007421553,0.024435876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969441,0.00012026746,0.00013696754,0.00015180516,0.0010523226,0.001594543],"domain_scores_gemma":[0.99053276,0.00056219,0.001234566,0.0001490151,0.0034634185,0.0040580607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013838019,0.00038883876,0.0008616495,0.0026420297,0.0034437992,0.0061741625,0.0012712453,0.003350051,0.00791669],"category_scores_gemma":[0.006712499,0.0005521189,0.0011578817,0.0061137574,0.0011056741,0.001370362,0.001472991,0.0037019975,0.0005194145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001311023,0.0002809388,0.5237716,0.00045691503,0.00044618634,0.0017343225,0.0024754205,0.004710944,0.0007034058,0.02645318,0.37644708,0.061208967],"study_design_scores_gemma":[0.00014065845,0.00005598956,0.89694834,0.00015801251,0.00010405862,0.00020371124,0.0028895375,0.0026317644,0.00024903705,0.0011908946,0.095346,0.00008196174],"about_ca_topic_score_codex":0.9958889,"about_ca_topic_score_gemma":0.99849176,"teacher_disagreement_score":0.11571252,"about_ca_system_score_codex":0.11571252,"about_ca_system_score_gemma":0.15011367,"threshold_uncertainty_score":0.83955705},"labels":[],"label_agreement":null},{"id":"W4244986734","doi":"10.2165/00151234-200905850-00020","title":"Untreated maternal depression costly in Canada","year":2009,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Depression (economics); Psychiatry; Public health; Medicine; Psychology; Economics; Nursing; Keynesian economics","score_opus":0.015624205610984244,"score_gpt":0.3283844411967805,"score_spread":0.31276023558579624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244986734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59000105,0.027572472,0.00029120388,0.29147962,0.0018712276,0.00018293568,0.015034712,0.000076996876,0.07348981],"genre_scores_gemma":[0.92844343,0.019008022,0.00042638186,0.026947357,0.0006199881,0.00005237182,0.0024676793,0.000036268768,0.02199844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990753,0.000088805864,0.000045780573,0.000051811414,0.00028052693,0.00045785093],"domain_scores_gemma":[0.99463993,0.00037667807,0.0006691539,0.000063290354,0.0011121249,0.0031387836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000360066,0.00013796068,0.00030365674,0.00067928014,0.002649175,0.0018999423,0.0009164727,0.0013979699,0.009232974],"category_scores_gemma":[0.0036487698,0.00034185254,0.00047358044,0.00193447,0.00055405276,0.00039241437,0.00068470783,0.0028377494,0.0002264553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010843301,0.00042216547,0.5371314,0.00063869165,0.00036834888,0.0034818794,0.0013902463,0.00117256,0.0006057845,0.01570232,0.30202678,0.13597542],"study_design_scores_gemma":[0.0004172076,0.00014298131,0.9042928,0.0007447932,0.00024348446,0.0009856486,0.004110539,0.0014770776,0.000196725,0.0016429176,0.08566578,0.00008004479],"about_ca_topic_score_codex":0.9911679,"about_ca_topic_score_gemma":0.99742496,"teacher_disagreement_score":0.053422783,"about_ca_system_score_codex":0.053422783,"about_ca_system_score_gemma":0.10519162,"threshold_uncertainty_score":0.3876112},"labels":[],"label_agreement":null},{"id":"W4245178157","doi":"10.2165/00151234-200905870-00028","title":"According to the Royal Pharmaceutical Society of Great Britain, at least a quarter of patients with heart disease do not take vital medicines they have been prescribed","year":2009,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Quality of Life Research; Health economics; Public health; History; Nursing","score_opus":0.049151494112189296,"score_gpt":0.371596385363541,"score_spread":0.32244489125135173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245178157","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016145246,0.054204408,0.0012272386,0.7067699,0.06605467,0.00022524547,0.0054996586,0.0008880131,0.1489856],"genre_scores_gemma":[0.10078092,0.03935919,0.0030478465,0.29308966,0.022696344,0.00039073534,0.0034642334,0.00023222521,0.5369388],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99730694,0.00029805274,0.00023590619,0.0002244638,0.0015289775,0.0004057009],"domain_scores_gemma":[0.9925566,0.002999627,0.000880382,0.00041059885,0.0018524209,0.0013002662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017795525,0.0006221238,0.00073408475,0.00079575984,0.001247811,0.0027358138,0.00047482803,0.008375038,0.028330505],"category_scores_gemma":[0.012324306,0.000563341,0.0005770216,0.00091679924,0.0010480718,0.0016200822,0.0009154141,0.0083275875,0.014452036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027387825,0.000068337395,0.0019379269,0.00026638337,0.000041274612,0.00024318871,0.00008910412,0.00008145149,0.00064748357,0.0030667514,0.9329773,0.06030695],"study_design_scores_gemma":[0.00018516378,0.00015736002,0.015035323,0.00018986673,0.000038810253,0.00024222613,0.00008431538,0.00015378764,0.0003846894,0.00038337236,0.9831013,0.000043846743],"about_ca_topic_score_codex":0.016579324,"about_ca_topic_score_gemma":0.026731368,"teacher_disagreement_score":0.028330505,"about_ca_system_score_codex":0.0015563249,"about_ca_system_score_gemma":0.0039739776,"threshold_uncertainty_score":0.09477496},"labels":[],"label_agreement":null},{"id":"W4245476379","doi":"10.2165/00151234-201206680-00033","title":"A report released by the Canadian Diabetes Association (CDA) recommends that Canada's drug review process be enhanced to ensure wider drug access.","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Quality of Life Research; Process (computing); Association (psychology); Business; Public health; Medicine; Pharmacology; Computer science; Psychology; Nursing","score_opus":0.048734976936854205,"score_gpt":0.43756325615396463,"score_spread":0.38882827921711044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245476379","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044312514,0.004395981,0.002325761,0.8395901,0.04300324,0.00074918877,0.008051858,0.0020098244,0.09544276],"genre_scores_gemma":[0.02347686,0.0068236287,0.008178451,0.7119651,0.009864831,0.000324199,0.006711812,0.0005593934,0.23209581],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9567598,0.0017008865,0.0016037928,0.0008223322,0.035040256,0.0040728687],"domain_scores_gemma":[0.8403914,0.03138675,0.0055873264,0.0029482986,0.09368537,0.0260008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020804897,0.00091043423,0.0010659853,0.003961715,0.0078077363,0.008868962,0.003303074,0.018441658,0.019549161],"category_scores_gemma":[0.07966328,0.00088303373,0.0023173918,0.0031950895,0.0025497177,0.0029644165,0.0022439577,0.016650746,0.005467374],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034649212,0.00003758533,0.001170251,0.00008390969,0.000014267306,0.00009866906,0.00009060929,0.000033222215,0.00019889751,0.0011720867,0.98758507,0.009480743],"study_design_scores_gemma":[0.000072285184,0.00005898676,0.011573409,0.00025144257,0.000056544453,0.00009993552,0.00034495647,0.00021542843,0.0005548276,0.00044846075,0.98624796,0.000075744254],"about_ca_topic_score_codex":0.83886266,"about_ca_topic_score_gemma":0.91210246,"teacher_disagreement_score":0.9739866,"about_ca_system_score_codex":0.026013387,"about_ca_system_score_gemma":0.19263345,"threshold_uncertainty_score":0.32417262},"labels":[],"label_agreement":null},{"id":"W4246410034","doi":"10.2165/00151234-201106250-00034","title":"Investigation into Herceptin funding in Ontario","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Vitamin K Research Studies","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine; Nursing","score_opus":0.13310672145570052,"score_gpt":0.37143286128963104,"score_spread":0.23832613983393053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246410034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.813894,0.0040896866,0.0001773437,0.06758599,0.00023380943,0.0003942785,0.0034002888,0.000019788185,0.11020475],"genre_scores_gemma":[0.9682949,0.0029874712,0.00032940594,0.007476503,0.00008250368,0.00014693094,0.0005177277,0.000015805319,0.020148685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99383473,0.0011105333,0.00027397505,0.0002306261,0.0021683942,0.0023817115],"domain_scores_gemma":[0.96777624,0.008731246,0.0049209516,0.00079121365,0.01011791,0.0076624732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041394606,0.00014154005,0.00031200543,0.0015218685,0.005687077,0.0037621756,0.0014164924,0.0012690786,0.00649714],"category_scores_gemma":[0.021194227,0.00050475483,0.0004074348,0.0043041282,0.0017828845,0.0009830254,0.0019510104,0.0012337327,0.00024699705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028261035,0.00033633734,0.79395276,0.0013169156,0.00027585233,0.0018697717,0.021749806,0.0004892924,0.0013460398,0.042708933,0.06073301,0.07239525],"study_design_scores_gemma":[0.000508789,0.00034287822,0.82717276,0.00092147576,0.00026026863,0.00037060556,0.032727215,0.0004607708,0.00066449534,0.0015372693,0.13497567,0.000057781708],"about_ca_topic_score_codex":0.9809553,"about_ca_topic_score_gemma":0.9942662,"teacher_disagreement_score":0.107310385,"about_ca_system_score_codex":0.107310385,"about_ca_system_score_gemma":0.21956612,"threshold_uncertainty_score":0.778595},"labels":[],"label_agreement":null},{"id":"W4246418223","doi":"10.1007/bf03278957","title":"Infliximab not worth it in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Microscopic Colitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Infliximab; Quality of Life Research; Medicine; Public health; Internal medicine; Nursing; Tumor necrosis factor alpha","score_opus":0.031419871673688315,"score_gpt":0.31626177457414867,"score_spread":0.28484190290046035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246418223","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018397586,0.01272228,0.00009620719,0.89259636,0.013581326,0.000028902814,0.0011396664,0.0000689495,0.06136881],"genre_scores_gemma":[0.24865745,0.03441365,0.00077198347,0.5092784,0.01332846,0.00003454748,0.0016441345,0.0002120227,0.19165933],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980142,0.000095641095,0.000106330066,0.000105261606,0.000979304,0.00069927255],"domain_scores_gemma":[0.98963493,0.00073855196,0.0004551469,0.00011889044,0.003555347,0.0054971133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010232413,0.00026616405,0.0005583397,0.0009865424,0.0042430414,0.0035014648,0.0010654681,0.0074561355,0.017130114],"category_scores_gemma":[0.0060665924,0.00037029322,0.00053715473,0.0018429875,0.0013226804,0.0009813588,0.0007051901,0.008891772,0.0009525251],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033071465,0.00007696613,0.010537927,0.00015082292,0.00005210839,0.0011927257,0.000176803,0.00014301979,0.00030110564,0.0048511364,0.9403166,0.041870147],"study_design_scores_gemma":[0.00047429436,0.00013306133,0.068132415,0.00060455885,0.00018268664,0.00076657574,0.0013047269,0.00038129216,0.0003938234,0.0017763892,0.92574567,0.00010446762],"about_ca_topic_score_codex":0.9645241,"about_ca_topic_score_gemma":0.98825794,"teacher_disagreement_score":0.03547591,"about_ca_system_score_codex":0.03403965,"about_ca_system_score_gemma":0.1264657,"threshold_uncertainty_score":0.24697608},"labels":[],"label_agreement":null},{"id":"W4246761610","doi":"10.1007/s40274-021-7755-3","title":"Weekly rifapentine + isoniazid for latent TB infections saves costs in Nunavut, Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rifapentine; Isoniazid; Quality of Life Research; Medicine; Latent tuberculosis; Public health; Environmental health; Tuberculosis; Mycobacterium tuberculosis","score_opus":0.03145654159372338,"score_gpt":0.37539017667699887,"score_spread":0.34393363508327546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246761610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7607285,0.0307266,0.0004120011,0.13128941,0.0022852146,0.0004097824,0.014593457,0.00021886869,0.059336256],"genre_scores_gemma":[0.93017906,0.01680872,0.0013400471,0.013510598,0.00049981877,0.000118445605,0.0025830064,0.00010611463,0.034854136],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99929976,0.00008180147,0.00003815952,0.00004961746,0.00022065932,0.00031007043],"domain_scores_gemma":[0.99651366,0.00019031503,0.00019430311,0.000030343115,0.0008600324,0.0022113184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885931,0.0002822326,0.00031178986,0.0006095039,0.0029455172,0.0019773233,0.0015922906,0.0008031172,0.008203922],"category_scores_gemma":[0.0027987715,0.00037812153,0.00046813927,0.0011612318,0.0006056703,0.0004695779,0.00093268446,0.001723129,0.0003219294],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023422164,0.0011319616,0.35841712,0.0010107515,0.00045454633,0.001612685,0.0019974716,0.0030516377,0.0014319088,0.003594482,0.3857426,0.23921266],"study_design_scores_gemma":[0.0011960161,0.0005132588,0.88532054,0.0015494766,0.00048056678,0.0005914377,0.00936209,0.0038533784,0.0006528606,0.0009610148,0.09533235,0.00018699866],"about_ca_topic_score_codex":0.99696475,"about_ca_topic_score_gemma":0.9991316,"teacher_disagreement_score":0.05576195,"about_ca_system_score_codex":0.05576195,"about_ca_system_score_gemma":0.11660077,"threshold_uncertainty_score":0.40458316},"labels":[],"label_agreement":null},{"id":"W4247730375","doi":"10.2165/00151234-201005990-00027","title":"Seek and Treat to kick off in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.02739122967409572,"score_gpt":0.41961702696753395,"score_spread":0.3922257972934382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247730375","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28716424,0.014013004,0.0003759369,0.50417984,0.0056970823,0.00030834266,0.007702052,0.00017707727,0.18038255],"genre_scores_gemma":[0.7085258,0.00936148,0.0006245279,0.13303696,0.0011698749,0.00012635847,0.0021299752,0.00016581273,0.1448592],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969242,0.00013085413,0.000085041356,0.00012563085,0.000864394,0.001869854],"domain_scores_gemma":[0.98610514,0.00052491867,0.0005673446,0.000084461615,0.0023162952,0.010401869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083718164,0.00026817253,0.0005095092,0.0011554528,0.009307827,0.003738296,0.0018467184,0.0044513727,0.019611958],"category_scores_gemma":[0.00476327,0.00056385883,0.0006344546,0.0024329026,0.0016033432,0.001012737,0.0018929273,0.008073722,0.0009777211],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046498957,0.0004844256,0.13216363,0.00039220293,0.00010684392,0.0024878338,0.004241839,0.00045657635,0.00040412633,0.011638967,0.7520035,0.095155016],"study_design_scores_gemma":[0.00046871245,0.00023096227,0.5497767,0.0013374066,0.00021980138,0.0012575478,0.032270268,0.001434414,0.00038835377,0.002213358,0.41018367,0.00021893361],"about_ca_topic_score_codex":0.9950767,"about_ca_topic_score_gemma":0.9991253,"teacher_disagreement_score":0.075000554,"about_ca_system_score_codex":0.075000554,"about_ca_system_score_gemma":0.23125766,"threshold_uncertainty_score":0.54416966},"labels":[],"label_agreement":null},{"id":"W4248226877","doi":"10.2165/00151234-201006080-00020","title":"Hypoglycaemia exacts extra costs in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Services Management and Policy","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Economics; Public health; Medicine; Nursing","score_opus":0.04313908097705882,"score_gpt":0.4395245993307293,"score_spread":0.3963855183536705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248226877","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13502337,0.021502797,0.0002971458,0.7126775,0.010958443,0.00009443385,0.00862202,0.0002577024,0.11056665],"genre_scores_gemma":[0.7251203,0.027928106,0.0008142535,0.15058453,0.0062154327,0.00004931778,0.004322198,0.00024409489,0.08472176],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99485576,0.00024178531,0.00026036953,0.00019225875,0.0025029324,0.0019469197],"domain_scores_gemma":[0.97924656,0.0015279531,0.0015035028,0.00027164086,0.0068057333,0.010644476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015587615,0.00038342096,0.0006285237,0.0021777207,0.004220455,0.005534561,0.0017910729,0.0053239116,0.016247557],"category_scores_gemma":[0.014066339,0.00071646005,0.0013519401,0.004279072,0.0014608263,0.001358286,0.0015873127,0.0062596337,0.000691104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085809367,0.00024170692,0.08838275,0.0005503231,0.00030506257,0.0010976372,0.00090246997,0.0014779046,0.00034599315,0.013189177,0.78247476,0.11017416],"study_design_scores_gemma":[0.0005132803,0.00021838161,0.4754283,0.0011987095,0.0004444785,0.00071562827,0.004708995,0.0020386185,0.0003739443,0.0040659653,0.51000386,0.00028984644],"about_ca_topic_score_codex":0.9942011,"about_ca_topic_score_gemma":0.99735355,"teacher_disagreement_score":0.09465717,"about_ca_system_score_codex":0.09465717,"about_ca_system_score_gemma":0.20869306,"threshold_uncertainty_score":0.68678904},"labels":[],"label_agreement":null},{"id":"W4249070868","doi":"10.2165/00151234-200404670-00014","title":"Additional pertussis booster warranted among Canadian teens","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Booster (rocketry); Quality of Life Research; Medicine; Pediatrics; Public health","score_opus":0.016505900574232322,"score_gpt":0.3268944248113092,"score_spread":0.31038852423707686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249070868","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8107185,0.0064634685,0.00026989277,0.105538234,0.0019584466,0.00034599108,0.003348445,0.00019317748,0.071163855],"genre_scores_gemma":[0.96375,0.0042658905,0.0007105327,0.017599402,0.00040951103,0.000067156536,0.0009386728,0.000028031742,0.012230862],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887437,0.000078373,0.000037144633,0.000068497735,0.00037588307,0.0005656903],"domain_scores_gemma":[0.99660695,0.00025928405,0.00031092577,0.000038504048,0.0009593102,0.0018249617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071964477,0.00017512948,0.00030282987,0.0008650573,0.00351798,0.0011722913,0.00074244064,0.0018769302,0.014523937],"category_scores_gemma":[0.0048808362,0.00020793821,0.0005904141,0.00109166,0.00033873232,0.00048464,0.00044811054,0.0022717847,0.00045437718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010106107,0.0010539894,0.631853,0.00041065956,0.00008116301,0.0038198533,0.0033805105,0.00019289997,0.0015555568,0.0016341174,0.16602834,0.18897936],"study_design_scores_gemma":[0.00026877064,0.0007539851,0.8887774,0.0009122255,0.00031775836,0.0016794547,0.01409206,0.0006364693,0.0010014385,0.0003678197,0.09111232,0.000080252525],"about_ca_topic_score_codex":0.9469123,"about_ca_topic_score_gemma":0.9757983,"teacher_disagreement_score":0.05308771,"about_ca_system_score_codex":0.018038975,"about_ca_system_score_gemma":0.044957373,"threshold_uncertainty_score":0.1308825},"labels":[],"label_agreement":null},{"id":"W4249484723","doi":"10.2165/00151234-200504770-00015","title":"Osteoporosis treatment suboptimal in Canada","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Ovarian function and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Osteoporosis; Medicine; Public health; Internal medicine; Pathology","score_opus":0.018393757534471953,"score_gpt":0.3015883457465346,"score_spread":0.2831945882120626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249484723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6901524,0.01612003,0.000281041,0.16384006,0.0012173967,0.00035134915,0.018266914,0.000088989604,0.1096819],"genre_scores_gemma":[0.94487107,0.007937565,0.00056150684,0.02874013,0.0002202834,0.00007878949,0.002645223,0.000049928713,0.014895521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788886,0.00013994673,0.00012936493,0.00016247582,0.00069058314,0.0009888883],"domain_scores_gemma":[0.99367887,0.00030114202,0.00082305516,0.00006842793,0.0020094847,0.00311905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005115521,0.00019350834,0.0005494862,0.0016112346,0.0071028015,0.0029011944,0.0012750591,0.0016383086,0.014320242],"category_scores_gemma":[0.0038622518,0.0004679434,0.00059626374,0.0066596414,0.001049652,0.0006957232,0.0012950808,0.0031440419,0.0004679182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029058979,0.00033689532,0.7771639,0.00038706214,0.0001979805,0.002048545,0.003108852,0.00045275505,0.0003299387,0.00904559,0.14972213,0.056915592],"study_design_scores_gemma":[0.00018952055,0.0000629011,0.9271072,0.00065015367,0.00012833634,0.0009879055,0.012467453,0.00079202134,0.00012443768,0.001240604,0.056180965,0.00006855612],"about_ca_topic_score_codex":0.99697185,"about_ca_topic_score_gemma":0.999175,"teacher_disagreement_score":0.05793088,"about_ca_system_score_codex":0.05793088,"about_ca_system_score_gemma":0.17195253,"threshold_uncertainty_score":0.4203199},"labels":[],"label_agreement":null},{"id":"W4249515208","doi":"10.2165/00151234-200404530-00026","title":"Canadian funding praised by WHO, drugs bill to be approved","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Political science; Medicine; Public health","score_opus":0.036562466683443595,"score_gpt":0.3371623758934032,"score_spread":0.3005999092099596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249515208","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014039887,0.013158608,0.00026604405,0.69761944,0.05144298,0.00012530769,0.004232567,0.0003381192,0.2314129],"genre_scores_gemma":[0.01436066,0.006383965,0.00076395815,0.19294325,0.004514768,0.000050986546,0.0014122031,0.00020115284,0.77936894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900356,0.00040396428,0.00024338254,0.00047497253,0.0066816113,0.0021604616],"domain_scores_gemma":[0.98239267,0.0010402275,0.00030214575,0.00049037085,0.011161343,0.004613198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004286309,0.00083807204,0.0010628313,0.002692097,0.008245038,0.010805985,0.001620066,0.014411877,0.0495194],"category_scores_gemma":[0.021078268,0.00075938395,0.0014247504,0.002724164,0.0028850741,0.001901014,0.001678355,0.013968619,0.011386025],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023176213,0.0000048443785,0.00014457507,0.000019225268,0.0000061833275,0.00003027087,0.000018499835,0.000020289632,0.000031073065,0.0039691543,0.9922334,0.003499446],"study_design_scores_gemma":[0.000028054792,0.000006725763,0.001326338,0.000064414024,0.00001232085,0.000026081327,0.000057623463,0.000031519423,0.000049775066,0.0006534207,0.99773175,0.000012066445],"about_ca_topic_score_codex":0.93006295,"about_ca_topic_score_gemma":0.966073,"teacher_disagreement_score":0.06993705,"about_ca_system_score_codex":0.051538512,"about_ca_system_score_gemma":0.21861853,"threshold_uncertainty_score":0.3739398},"labels":[],"label_agreement":null},{"id":"W4249590968","doi":"10.2165/00151234-200504830-00014","title":"Infliximab worth it for ankylosing spondylitis in Canada . . .","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ankylosing spondylitis; Infliximab; Medicine; Spondylitis; Internal medicine; Tumor necrosis factor alpha","score_opus":0.0706255941152727,"score_gpt":0.4626623484717373,"score_spread":0.3920367543564646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249590968","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1234823,0.05963652,0.00024265547,0.6954704,0.005619278,0.00012607279,0.0038559383,0.00011746883,0.11144938],"genre_scores_gemma":[0.656825,0.063344404,0.0014233231,0.14830165,0.005153082,0.000046041834,0.0032775118,0.00009383045,0.12153533],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999665,0.000018496456,0.000015282478,0.000016967895,0.00013661075,0.00014773002],"domain_scores_gemma":[0.9984295,0.000067856316,0.00007155787,0.000010403325,0.00042114893,0.0009996002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019774289,0.00010416783,0.00018930092,0.00042108088,0.0018737939,0.0008571853,0.0003546513,0.0014167792,0.010024558],"category_scores_gemma":[0.001094497,0.000110706365,0.00019442734,0.0008622261,0.00048462566,0.0003533771,0.00021290095,0.0018785283,0.00061735156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008098568,0.00026633512,0.06563284,0.00032862715,0.000052034957,0.0028719367,0.0004981686,0.00017764965,0.0012151654,0.0025715681,0.73405635,0.19151947],"study_design_scores_gemma":[0.0008630017,0.00045702016,0.3726554,0.0013213784,0.00028049713,0.002894633,0.0030806672,0.0006652417,0.00055448787,0.0013786679,0.61577433,0.000074749674],"about_ca_topic_score_codex":0.93102986,"about_ca_topic_score_gemma":0.9872339,"teacher_disagreement_score":0.068970144,"about_ca_system_score_codex":0.0110578425,"about_ca_system_score_gemma":0.043963462,"threshold_uncertainty_score":0.13875258},"labels":[],"label_agreement":null},{"id":"W4249731256","doi":"10.1007/bf03276389","title":"Rx to non-Rx status switch recommended for emergency OC in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Medical emergency; Public health; Nursing","score_opus":0.028153726463321142,"score_gpt":0.34392676331545036,"score_spread":0.3157730368521292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249731256","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.820894,0.0039689345,0.00034307977,0.08785755,0.0014483255,0.00028652762,0.007971969,0.00014229146,0.07708736],"genre_scores_gemma":[0.9655117,0.0017977558,0.00034872614,0.013935416,0.00055392366,0.000032705142,0.0019375514,0.000040329884,0.015841812],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990711,0.000053074324,0.000052370415,0.00007644627,0.00028021826,0.00046670565],"domain_scores_gemma":[0.9952833,0.0005775755,0.00048518603,0.000051297662,0.0012841984,0.0023184353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046418296,0.00013666926,0.0003380742,0.00074310775,0.0017943385,0.0010895826,0.00086258317,0.0015221845,0.009644568],"category_scores_gemma":[0.00456986,0.00020529954,0.0003476221,0.001398934,0.0004146978,0.0002791569,0.00031275593,0.0020123904,0.0003112882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024140098,0.00055121444,0.73523307,0.00024865163,0.00013457466,0.0066803987,0.0010554277,0.0011203518,0.00081035093,0.0018696944,0.17888659,0.07099561],"study_design_scores_gemma":[0.00048265432,0.0001860908,0.9603604,0.00017218925,0.00014325506,0.0012878196,0.002592074,0.0016766927,0.00036006793,0.00033267323,0.032366183,0.000039918938],"about_ca_topic_score_codex":0.97501945,"about_ca_topic_score_gemma":0.9916135,"teacher_disagreement_score":0.024980545,"about_ca_system_score_codex":0.019758243,"about_ca_system_score_gemma":0.04539698,"threshold_uncertainty_score":0.14335674},"labels":[],"label_agreement":null},{"id":"W4249836732","doi":"10.1007/s40274-013-0696-8","title":"Quebec's decision to cap price of PPIs \"misguided\"","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Economics; Law and economics; Public health; Medicine","score_opus":0.21739077562156997,"score_gpt":0.47571594499884484,"score_spread":0.2583251693772749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249836732","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008136572,0.0027179886,0.0015577268,0.87102723,0.017114963,0.00016659734,0.0018925515,0.00058275316,0.09680364],"genre_scores_gemma":[0.062549695,0.0010654851,0.0019082101,0.7726639,0.004234482,0.00011168158,0.00039810795,0.00014522248,0.15692315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881838,0.0015724091,0.0004935062,0.00092603924,0.0068004006,0.0020238743],"domain_scores_gemma":[0.9755375,0.0064376527,0.00097645505,0.00068128586,0.012608611,0.0037584857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008312456,0.0008676296,0.00094938575,0.0017757034,0.0040794685,0.008555786,0.0022350184,0.025408454,0.013047027],"category_scores_gemma":[0.03408346,0.00089649844,0.0018952623,0.0016514483,0.0031751194,0.0015539348,0.0013620827,0.02015334,0.0026570456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016139119,0.000038052574,0.0025142129,0.00007736894,0.00007864813,0.0003376682,0.00012393884,0.0005251233,0.00055510004,0.019996105,0.96115017,0.014442228],"study_design_scores_gemma":[0.00022462093,0.00006840087,0.009550661,0.00016603184,0.00009638353,0.00017721746,0.0001307627,0.0012410729,0.0007664286,0.0027695552,0.98470783,0.00010096092],"about_ca_topic_score_codex":0.87956876,"about_ca_topic_score_gemma":0.9245323,"teacher_disagreement_score":0.9537591,"about_ca_system_score_codex":0.046240926,"about_ca_system_score_gemma":0.08154586,"threshold_uncertainty_score":0.33550298},"labels":[],"label_agreement":null},{"id":"W4249843933","doi":"10.2165/00151234-201106410-00011","title":"Antibacterial stewardship programme saves cost in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Stewardship (theology); Business; Public health; Medicine; Political science; Nursing; Law","score_opus":0.034024783555338216,"score_gpt":0.2732441944442627,"score_spread":0.23921941088892446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249843933","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40664804,0.01574388,0.0002984867,0.4714957,0.0038781085,0.00025204758,0.005385209,0.0004291651,0.095869444],"genre_scores_gemma":[0.8134312,0.012665551,0.0011071021,0.07784598,0.0014347625,0.0000805195,0.002164856,0.00013551334,0.091134585],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979698,0.00011608888,0.00005779761,0.00007409409,0.0008680144,0.0009142277],"domain_scores_gemma":[0.9882159,0.0005800502,0.00039436246,0.00009832859,0.0025755863,0.008135709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007006704,0.00027138455,0.00036956285,0.001110842,0.003454571,0.002495062,0.0013415503,0.0027895826,0.012723205],"category_scores_gemma":[0.0054806885,0.00042867506,0.0006179729,0.0016455483,0.0009225726,0.0006092846,0.0009142552,0.0027926497,0.00037911593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011210709,0.0009145935,0.10839007,0.0005184313,0.0002386447,0.0014545084,0.000876478,0.0014000336,0.001026586,0.0067199976,0.6796972,0.19764245],"study_design_scores_gemma":[0.00095104624,0.0006124058,0.70862347,0.000573098,0.0003208363,0.0005686777,0.0026441782,0.002616142,0.00077528955,0.0010345083,0.28113085,0.00014960808],"about_ca_topic_score_codex":0.9924177,"about_ca_topic_score_gemma":0.99717474,"teacher_disagreement_score":0.06240301,"about_ca_system_score_codex":0.06240301,"about_ca_system_score_gemma":0.21856694,"threshold_uncertainty_score":0.4527676},"labels":[],"label_agreement":null},{"id":"W4249967566","doi":"10.1007/s40274-020-6514-1","title":"Healthcare administration expenditure greater in USA than Canada","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health administration; Quality of Life Research; Health care; Administration (probate law); Health economics; Public health; Public expenditure; Business; Public economics; Public administration; Public finance; Economics; Political science; Medicine; Economic growth; Nursing; Law","score_opus":0.07905782130683284,"score_gpt":0.33323051698200024,"score_spread":0.2541726956751674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249967566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56480604,0.014576655,0.00088332564,0.16537078,0.0021651844,0.000089341884,0.046642598,0.0003363451,0.20512968],"genre_scores_gemma":[0.9077986,0.007895228,0.00071122986,0.018580757,0.00047794043,0.00002651592,0.010168378,0.000113396374,0.05422805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998546,0.00010043717,0.00006175645,0.0001046505,0.0005448463,0.00064229936],"domain_scores_gemma":[0.9957027,0.00028053668,0.0005130907,0.000057114074,0.0019884463,0.0014580967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053212047,0.00023728797,0.00039579358,0.0019952576,0.0015143919,0.0035227856,0.0004520389,0.0011378201,0.009890697],"category_scores_gemma":[0.0036226837,0.00023453597,0.00081363093,0.0045356513,0.0003857176,0.00070886704,0.000688505,0.0017429489,0.00040444042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005038182,0.00012917668,0.48479626,0.00036349814,0.00059308467,0.00058497215,0.00062803645,0.001529247,0.00072889635,0.022512095,0.3986733,0.088957705],"study_design_scores_gemma":[0.000048340837,0.000039371575,0.82951087,0.00024265714,0.00026255363,0.00029946302,0.002239287,0.0011095274,0.00059771317,0.0006555068,0.16494814,0.000046586123],"about_ca_topic_score_codex":0.9891783,"about_ca_topic_score_gemma":0.99538475,"teacher_disagreement_score":0.03415322,"about_ca_system_score_codex":0.03415322,"about_ca_system_score_gemma":0.05992846,"threshold_uncertainty_score":0.24780011},"labels":[],"label_agreement":null},{"id":"W4250440661","doi":"10.1007/s40274-017-4035-3","title":"High-risk screening for lung cancer cost effective in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Lung cancer; Public health; Health economics; Business; Actuarial science; Medicine; Risk analysis (engineering); Environmental health; Oncology; Nursing","score_opus":0.0202402612847341,"score_gpt":0.37652684159130384,"score_spread":0.35628658030656973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250440661","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34562707,0.027645264,0.00059661694,0.5039495,0.0032053357,0.00029514168,0.01664249,0.00029949888,0.10173908],"genre_scores_gemma":[0.9186465,0.016014397,0.0012885607,0.03779561,0.0013515459,0.00006205684,0.0041124746,0.000087244676,0.020641522],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99742883,0.00022683808,0.00012778054,0.00011868051,0.0012093595,0.00088847044],"domain_scores_gemma":[0.98533785,0.0019651481,0.0008765284,0.00015266622,0.0055026347,0.0061651804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011039954,0.00028549318,0.00046161356,0.0013433159,0.0018446784,0.0029462439,0.0012618388,0.0016597883,0.009706116],"category_scores_gemma":[0.012378116,0.00042975237,0.0008592162,0.0023939083,0.0008316926,0.0008011318,0.0008035149,0.0027278052,0.00023832529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012756618,0.00054432696,0.28042638,0.0010313658,0.000665214,0.0009684429,0.00071157655,0.0046991426,0.0006435296,0.010949267,0.52186394,0.17622113],"study_design_scores_gemma":[0.00081195915,0.00024839208,0.8668509,0.0010266023,0.0008070908,0.00043413445,0.0019319424,0.006993657,0.0004900956,0.001973664,0.118296504,0.00013509313],"about_ca_topic_score_codex":0.9957526,"about_ca_topic_score_gemma":0.99812335,"teacher_disagreement_score":0.08600931,"about_ca_system_score_codex":0.08600931,"about_ca_system_score_gemma":0.19967395,"threshold_uncertainty_score":0.6240441},"labels":[],"label_agreement":null},{"id":"W4250489109","doi":"10.1007/s40274-012-0033-7","title":"A report released by the Canadian Diabetes Association (CDA) recommends that Canada's drug review process be enhanced to ensure wider drug access.","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Quality of Life Research; Process (computing); Association (psychology); Public health; Business; Environmental health; Medicine; Computer science; Pharmacology; Psychology; Nursing","score_opus":0.048734976936854205,"score_gpt":0.43756325615396463,"score_spread":0.38882827921711044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250489109","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044312514,0.004395981,0.002325761,0.8395901,0.04300324,0.00074918877,0.008051858,0.0020098244,0.09544276],"genre_scores_gemma":[0.02347686,0.0068236287,0.008178451,0.7119651,0.009864831,0.000324199,0.006711812,0.0005593934,0.23209581],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9567598,0.0017008865,0.0016037928,0.0008223322,0.035040256,0.0040728687],"domain_scores_gemma":[0.8403914,0.03138675,0.0055873264,0.0029482986,0.09368537,0.0260008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020804897,0.00091043423,0.0010659853,0.003961715,0.0078077363,0.008868962,0.003303074,0.018441658,0.019549161],"category_scores_gemma":[0.07966328,0.00088303373,0.0023173918,0.0031950895,0.0025497177,0.0029644165,0.0022439577,0.016650746,0.005467374],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034649212,0.00003758533,0.001170251,0.00008390969,0.000014267306,0.00009866906,0.00009060929,0.000033222215,0.00019889751,0.0011720867,0.98758507,0.009480743],"study_design_scores_gemma":[0.000072285184,0.00005898676,0.011573409,0.00025144257,0.000056544453,0.00009993552,0.00034495647,0.00021542843,0.0005548276,0.00044846075,0.98624796,0.000075744254],"about_ca_topic_score_codex":0.83886266,"about_ca_topic_score_gemma":0.91210246,"teacher_disagreement_score":0.9739866,"about_ca_system_score_codex":0.026013387,"about_ca_system_score_gemma":0.19263345,"threshold_uncertainty_score":0.32417262},"labels":[],"label_agreement":null},{"id":"W4250745188","doi":"10.1007/bf03266922","title":"Generics deal for pharmaceutical industry in Quebec?","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Pharmaceutical industry; Public health; Medicine; Pharmacology","score_opus":0.08134391400180845,"score_gpt":0.3750161646133117,"score_spread":0.29367225061150326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250745188","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08575048,0.018325185,0.0004863323,0.65752,0.0032101532,0.00016757117,0.010202794,0.00023356946,0.2241039],"genre_scores_gemma":[0.41432303,0.007812576,0.0007196895,0.15911178,0.0022628817,0.00006607023,0.0023011314,0.000091377035,0.41331136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983652,0.00013558302,0.00005063889,0.00012867273,0.0005071997,0.0008126561],"domain_scores_gemma":[0.9945716,0.0006449164,0.0006719964,0.00010659911,0.0016910624,0.0023138465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017665774,0.00025490264,0.00033335475,0.0009822531,0.0029027176,0.0051041874,0.0013031283,0.0066141053,0.052592304],"category_scores_gemma":[0.0048319777,0.00032384717,0.0005804448,0.0015294607,0.0010574124,0.0019842242,0.000664796,0.002746125,0.002614991],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004527741,0.00014095573,0.061223052,0.00036639778,0.00010749774,0.0009763444,0.0005183857,0.00068048114,0.001180665,0.041238204,0.8301438,0.06297159],"study_design_scores_gemma":[0.00016685741,0.000074745265,0.16150935,0.0002818829,0.000080978134,0.0003001126,0.001267684,0.0015119485,0.00047690223,0.0015741099,0.832686,0.00006942047],"about_ca_topic_score_codex":0.9614142,"about_ca_topic_score_gemma":0.98688763,"teacher_disagreement_score":0.052592304,"about_ca_system_score_codex":0.04532292,"about_ca_system_score_gemma":0.069559745,"threshold_uncertainty_score":0.3288424},"labels":[],"label_agreement":null},{"id":"W4250881677","doi":"10.2165/00151234-200604990-00023","title":"Canadian generic market grows, but new drug access lags","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Drug; Business; Economics; Public health; Medicine; Pharmacology","score_opus":0.04633601836258157,"score_gpt":0.31835120293496816,"score_spread":0.2720151845723866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250881677","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0776007,0.030358681,0.002356459,0.45657963,0.0039487337,0.00010643791,0.040414575,0.0010486246,0.38758624],"genre_scores_gemma":[0.7100231,0.02893723,0.0024430982,0.045116473,0.0027225763,0.000032248467,0.0114068715,0.00023977723,0.19907863],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786323,0.00006355858,0.000053813117,0.00017631824,0.0013241449,0.00051898585],"domain_scores_gemma":[0.9929092,0.0008088557,0.00060469605,0.00017866482,0.0030932978,0.0024053059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016495561,0.0007245201,0.00066077645,0.0026429147,0.0025391188,0.0064699296,0.00089122227,0.002518302,0.04346445],"category_scores_gemma":[0.0069540422,0.0003064519,0.00085139525,0.003541467,0.0013977402,0.0031157932,0.00093086803,0.002977775,0.003039434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006102006,0.00008162812,0.034075256,0.0005446545,0.00010027072,0.00044702654,0.00046796812,0.0017201857,0.0017400859,0.105832554,0.69873804,0.15564214],"study_design_scores_gemma":[0.00012422647,0.00007248332,0.14090903,0.00023720988,0.000125159,0.00024562803,0.00126004,0.002619383,0.0011110358,0.010145497,0.8430793,0.000071000206],"about_ca_topic_score_codex":0.96842927,"about_ca_topic_score_gemma":0.978874,"teacher_disagreement_score":0.044177704,"about_ca_system_score_codex":0.044177704,"about_ca_system_score_gemma":0.051725127,"threshold_uncertainty_score":0.32053316},"labels":[],"label_agreement":null},{"id":"W4251049664","doi":"10.1007/bf03276210","title":"Disparities in diabetes care delivery in Canada and the US","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Diabetes mellitus; Public health; Health economics; Medicine; Environmental health; Gerontology; Nursing","score_opus":0.008480071834728048,"score_gpt":0.2586075133668157,"score_spread":0.25012744153208766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251049664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90602803,0.009738085,0.00016373688,0.058045898,0.00051074737,0.000055309683,0.005489023,0.000028349628,0.019940762],"genre_scores_gemma":[0.9932327,0.0019644469,0.00012001003,0.002614967,0.00008849626,0.000013765498,0.0008244948,0.00000726364,0.00113396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970701,0.00026206035,0.0001701987,0.00018937561,0.00083807425,0.001470214],"domain_scores_gemma":[0.9934685,0.0005965548,0.00088563084,0.000096608965,0.0020439434,0.0029086957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012459803,0.00018650493,0.0005202831,0.0021927694,0.004818365,0.0026532754,0.0014214728,0.0014159583,0.0031017943],"category_scores_gemma":[0.0069442657,0.00026227182,0.000654823,0.007902388,0.0015078024,0.0010426701,0.0018813243,0.0021130133,0.00011666508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030244442,0.00028618673,0.91720444,0.00015590954,0.00017329786,0.0002475179,0.0047284397,0.00046003648,0.00010239288,0.0064292303,0.031786118,0.03812384],"study_design_scores_gemma":[0.000042058608,0.000030879208,0.98357683,0.00017398561,0.000076361495,0.00008211619,0.007116592,0.00042629422,0.000053517357,0.0007417802,0.007643815,0.00003581921],"about_ca_topic_score_codex":0.99501884,"about_ca_topic_score_gemma":0.9975176,"teacher_disagreement_score":0.046102256,"about_ca_system_score_codex":0.046102256,"about_ca_system_score_gemma":0.089333996,"threshold_uncertainty_score":0.33449686},"labels":[],"label_agreement":null},{"id":"W4252437751","doi":"10.1007/bf03278672","title":"Inadequate thromboprophylaxis common in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine","score_opus":0.025543460248884455,"score_gpt":0.2975303013503977,"score_spread":0.2719868411015133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252437751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82166153,0.015985278,0.00037568563,0.082212396,0.00079740636,0.0001992976,0.016392125,0.00012099002,0.062255222],"genre_scores_gemma":[0.98115736,0.0047026114,0.00033574473,0.006748194,0.00013481831,0.000023535893,0.0018130839,0.000027553666,0.0050569577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979467,0.0000959842,0.00017941892,0.0001652831,0.00091392366,0.0006987246],"domain_scores_gemma":[0.9872114,0.0006934412,0.0023508756,0.00018398244,0.0046542184,0.0049060904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055798696,0.00015535063,0.00036413642,0.0016802978,0.003161681,0.0018311806,0.001202189,0.000985834,0.008560318],"category_scores_gemma":[0.0071510044,0.0003079714,0.00039010742,0.0050786245,0.0007211813,0.0005408981,0.00075710966,0.002187041,0.0002218883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018776988,0.00014181848,0.8588465,0.00033779436,0.00013764657,0.0013868158,0.001428578,0.00031605002,0.00041520936,0.0024043072,0.07455856,0.05983896],"study_design_scores_gemma":[0.000033024764,0.00003163419,0.9768554,0.00024354151,0.00005282272,0.0005930993,0.0026060876,0.00037670124,0.00008500423,0.00025572855,0.018838206,0.000028842207],"about_ca_topic_score_codex":0.9936957,"about_ca_topic_score_gemma":0.9975865,"teacher_disagreement_score":0.039051797,"about_ca_system_score_codex":0.039051797,"about_ca_system_score_gemma":0.09467286,"threshold_uncertainty_score":0.28334194},"labels":[],"label_agreement":null},{"id":"W4252660209","doi":"10.1007/bf03269644","title":"NSAID-related GI disorders costly in Canada's elderly","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.007799019978490119,"score_gpt":0.28141762316589164,"score_spread":0.2736186031874015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252660209","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19832712,0.07581155,0.00020455457,0.6236618,0.008130848,0.000064447275,0.009443784,0.00013051738,0.084225304],"genre_scores_gemma":[0.6739101,0.13667303,0.0010288652,0.10921633,0.009955109,0.000041921227,0.0044750767,0.00007392874,0.06462571],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99944764,0.00003361044,0.000037232396,0.000021327329,0.00028259013,0.00017745617],"domain_scores_gemma":[0.9947537,0.00040608592,0.00048371678,0.000051443207,0.0024288087,0.0018761506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041709724,0.00018077745,0.00030348194,0.0010404325,0.0017525111,0.0022851056,0.00032518525,0.001405913,0.0103403395],"category_scores_gemma":[0.004245829,0.00016390297,0.00039776065,0.0019454603,0.0004982378,0.0006023435,0.00046117307,0.0016379468,0.00057078316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005912857,0.000084550025,0.18951273,0.0006520756,0.00012275238,0.0013864399,0.00055580644,0.00019611338,0.000529581,0.0019701123,0.64958096,0.15481758],"study_design_scores_gemma":[0.00011326444,0.000097398806,0.6278809,0.00081176974,0.0002210585,0.00096729596,0.0041254135,0.00030769565,0.00024720453,0.0004519905,0.36472508,0.000051012565],"about_ca_topic_score_codex":0.92786545,"about_ca_topic_score_gemma":0.9765356,"teacher_disagreement_score":0.072134554,"about_ca_system_score_codex":0.013325367,"about_ca_system_score_gemma":0.032577865,"threshold_uncertainty_score":0.14511871},"labels":[],"label_agreement":null},{"id":"W4253046517","doi":"10.1007/s40274-016-2925-4","title":"ASCO endorses Cancer Care Ontario treatment guidelines","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Cancer; Family medicine; Nursing; Internal medicine","score_opus":0.2915147588622064,"score_gpt":0.5500505289812848,"score_spread":0.2585357701190784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253046517","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002208025,0.001794321,0.00040051225,0.8218045,0.024201518,0.00029370535,0.0032106668,0.000283817,0.14580296],"genre_scores_gemma":[0.040706072,0.0064045466,0.005553446,0.49007708,0.021588368,0.0008827609,0.009748701,0.00065195945,0.42438707],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9615116,0.0049503455,0.002697558,0.0008146599,0.025771301,0.0042545362],"domain_scores_gemma":[0.7719751,0.032791387,0.01111601,0.005794267,0.14240009,0.03592312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016418342,0.00052029354,0.0009953898,0.0029658447,0.0066175335,0.0068192543,0.0027863043,0.014644927,0.061191868],"category_scores_gemma":[0.11907437,0.0008883829,0.0017108032,0.004912969,0.0028670456,0.0021425202,0.0031742211,0.012863154,0.01331885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016216258,0.00003090982,0.0007897745,0.00004953447,0.000007246856,0.000028377837,0.00009637103,0.000019007643,0.000025090903,0.0010901846,0.99103117,0.006816052],"study_design_scores_gemma":[0.0000711779,0.000020021218,0.004969592,0.00024090425,0.000022495758,0.00004067633,0.00022821195,0.00009971058,0.000056731624,0.0006331052,0.9935948,0.000022493165],"about_ca_topic_score_codex":0.68945396,"about_ca_topic_score_gemma":0.880211,"teacher_disagreement_score":0.31054604,"about_ca_system_score_codex":0.034385975,"about_ca_system_score_gemma":0.24069531,"threshold_uncertainty_score":0.6247498},"labels":[],"label_agreement":null},{"id":"W4253178590","doi":"10.1007/bf03279389","title":"High resource use, costs for type 1 DM in Canada vs US","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Resource (disambiguation); Resource use; Business; Economics; Natural resource economics; Public health; Computer science; Medicine; Computer network","score_opus":0.3509024066080205,"score_gpt":0.4395808854166129,"score_spread":0.08867847880859236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253178590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9383561,0.010326282,0.00010135177,0.012105926,0.00017834584,0.000045853834,0.024906969,0.000034225035,0.013944929],"genre_scores_gemma":[0.98805064,0.0027627058,0.00014911393,0.0012027606,0.000063205924,0.000012291696,0.0049343053,0.000015290176,0.0028095902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911433,0.000065005035,0.000060472903,0.00008355892,0.00031744997,0.00035915064],"domain_scores_gemma":[0.99521756,0.0005739196,0.0008117822,0.00006964766,0.0016669258,0.0016603384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000679608,0.00023532264,0.0005220571,0.0018586452,0.0017747656,0.0020652283,0.00088847434,0.0009130103,0.005724436],"category_scores_gemma":[0.0068103177,0.0003077102,0.0009697293,0.0049641314,0.0004981205,0.00067772757,0.0007755584,0.0016257679,0.00018729939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009902433,0.0001159928,0.94331366,0.00017914812,0.00034459,0.000310372,0.0005147174,0.0013328847,0.000118965785,0.002151611,0.03039769,0.020230195],"study_design_scores_gemma":[0.000048329195,0.000029792196,0.99463826,0.00008045251,0.00013737018,0.000097669195,0.0012467249,0.00063293864,0.000051968324,0.00017377743,0.0028361583,0.000026526552],"about_ca_topic_score_codex":0.99737203,"about_ca_topic_score_gemma":0.9985618,"teacher_disagreement_score":0.045886207,"about_ca_system_score_codex":0.045886207,"about_ca_system_score_gemma":0.04862722,"threshold_uncertainty_score":0.33292925},"labels":[],"label_agreement":null},{"id":"W4253917067","doi":"10.1007/s40274-014-1042-5","title":"Ticagrelor good value for money in ACS in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Value (mathematics); Value for money; Quality of Life Research; Business; Economics; Medicine; Mathematics; Internal medicine; Acute coronary syndrome; Public health; Public economics; Statistics","score_opus":0.011728007418592597,"score_gpt":0.290141817118358,"score_spread":0.2784138096997654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253917067","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10254282,0.02033315,0.00015836745,0.7790279,0.005949718,0.000055426346,0.004446613,0.000068026195,0.08741796],"genre_scores_gemma":[0.7957045,0.02780075,0.0007135999,0.119157225,0.005420303,0.00003614567,0.0019230903,0.00013135446,0.049113013],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976997,0.0001269348,0.000112433874,0.000105431944,0.0010226939,0.00093283475],"domain_scores_gemma":[0.9829412,0.0014364386,0.0010800887,0.0001277348,0.0054550837,0.008959323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011350617,0.00019127422,0.0005266673,0.001316267,0.0039932053,0.005421168,0.0009626596,0.0036316048,0.011456013],"category_scores_gemma":[0.009643835,0.00035824912,0.00054860185,0.00296858,0.0014198574,0.001135059,0.00092977774,0.0056203455,0.00051737134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005981091,0.00014511945,0.0703708,0.00029311975,0.00013558108,0.0013454902,0.001039613,0.0003721196,0.00026415204,0.0112654045,0.8404657,0.0737048],"study_design_scores_gemma":[0.0006833671,0.00018295099,0.41823974,0.0014552271,0.00049271947,0.0012129107,0.009448136,0.0018185432,0.0004462841,0.004425517,0.5613005,0.00029403588],"about_ca_topic_score_codex":0.9874042,"about_ca_topic_score_gemma":0.9959668,"teacher_disagreement_score":0.053111598,"about_ca_system_score_codex":0.053111598,"about_ca_system_score_gemma":0.13984165,"threshold_uncertainty_score":0.38535345},"labels":[],"label_agreement":null},{"id":"W4253997077","doi":"10.1007/s40274-013-0647-4","title":"Cardiovascular research in Canada: good return on investment","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Investment (military); Return on investment; Economics; Health economics; Business; Actuarial science; Public health; Medicine; Political science; Microeconomics; Economic growth; Law","score_opus":0.18665998838135112,"score_gpt":0.4550599772445519,"score_spread":0.26839998886320077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253997077","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031768999,0.0101843905,0.00038185072,0.9319148,0.02472201,0.00007452097,0.0014441755,0.00026876497,0.02783262],"genre_scores_gemma":[0.15499136,0.048377637,0.0060835136,0.63186187,0.035429485,0.00014511014,0.004912392,0.0004581469,0.11774048],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97029334,0.003046003,0.0010390023,0.0010830924,0.017046563,0.007491919],"domain_scores_gemma":[0.8139908,0.019586213,0.0034728777,0.00371452,0.06831672,0.090918936],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019447088,0.0015723543,0.0013834408,0.005212003,0.0052316627,0.016209409,0.0032269352,0.0280391,0.030238463],"category_scores_gemma":[0.06852755,0.0010123801,0.0021360635,0.0038535546,0.006319677,0.0050034286,0.005244714,0.0149146905,0.005548817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044758947,0.0001329008,0.0038921903,0.0002673553,0.00015558481,0.00066979055,0.00014983393,0.00038476885,0.00033851038,0.009053701,0.9253487,0.059159134],"study_design_scores_gemma":[0.00072310225,0.00025974098,0.030348847,0.0015070967,0.00022806646,0.0004629624,0.0013323816,0.0011759202,0.0004649269,0.009891844,0.95341116,0.00019387784],"about_ca_topic_score_codex":0.86376125,"about_ca_topic_score_gemma":0.89421254,"teacher_disagreement_score":0.9805529,"about_ca_system_score_codex":0.069008075,"about_ca_system_score_gemma":0.34028992,"threshold_uncertainty_score":0.50069094},"labels":[],"label_agreement":null},{"id":"W4255482650","doi":"10.2165/00151234-201206490-00031","title":"Denosumab available for PMO in Ontario","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Denosumab; Quality of Life Research; Medicine; Business; Public health; Internal medicine; Nursing","score_opus":0.06464038649937859,"score_gpt":0.37620207856215016,"score_spread":0.31156169206277157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255482650","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3984778,0.021294404,0.0005475634,0.24894696,0.0018780025,0.00034262473,0.038196143,0.00021949573,0.29009697],"genre_scores_gemma":[0.8335185,0.01269992,0.0008016617,0.023149082,0.0011654329,0.00008431337,0.0059204535,0.000081710125,0.12257883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926406,0.00003368843,0.000034721208,0.000039914157,0.00034642077,0.00028122903],"domain_scores_gemma":[0.99829966,0.00013147289,0.00026043478,0.000021145965,0.0004546054,0.00083270646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027811236,0.000117567324,0.00021678163,0.0004655524,0.0017045384,0.0010376594,0.00047579012,0.00081043097,0.015471257],"category_scores_gemma":[0.0015309455,0.00022854547,0.00037720668,0.001194156,0.0004227742,0.00027939174,0.00044672313,0.0010782029,0.00066603324],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035939768,0.00026872256,0.23358238,0.0013325805,0.00031860158,0.0043662447,0.0018135175,0.0010179604,0.004645267,0.0074038208,0.6008792,0.14077774],"study_design_scores_gemma":[0.0006464978,0.00017377899,0.50667924,0.0003452633,0.00018486156,0.00060636346,0.0020761425,0.0005365352,0.0007474686,0.0006693113,0.4872884,0.000046129877],"about_ca_topic_score_codex":0.9748497,"about_ca_topic_score_gemma":0.9941466,"teacher_disagreement_score":0.0251503,"about_ca_system_score_codex":0.021588465,"about_ca_system_score_gemma":0.053211216,"threshold_uncertainty_score":0.156636},"labels":[],"label_agreement":null},{"id":"W4255485385","doi":"10.2165/00151234-201206550-00035","title":"Expansion of Canadian insulin pump programme cost saving","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Insulin pump; Economics; Public health; Medicine; Diabetes mellitus; Endocrinology; Nursing; Type 1 diabetes","score_opus":0.04300395360708603,"score_gpt":0.3388789495350784,"score_spread":0.2958749959279924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255485385","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11323079,0.019979974,0.0038008736,0.59492964,0.0140494425,0.0005083427,0.007994772,0.0015389068,0.24396726],"genre_scores_gemma":[0.6621382,0.02296131,0.011902261,0.15739422,0.0110898055,0.00023381464,0.0072611286,0.00029088825,0.12672837],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99765897,0.00024252415,0.00007624204,0.00014971633,0.0012525199,0.00061991933],"domain_scores_gemma":[0.991789,0.0009264293,0.00028312366,0.00021698057,0.0031780659,0.0036063308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016500131,0.00062872743,0.00047294886,0.0013998236,0.0011311764,0.0026654343,0.001178223,0.0021607536,0.027921753],"category_scores_gemma":[0.008269975,0.00021835988,0.0014323614,0.0012684223,0.00069804105,0.0008984011,0.0009513199,0.0028839263,0.0010891161],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016996049,0.00059807976,0.0138094835,0.00049188285,0.00021837703,0.0007074087,0.00014693201,0.0035875603,0.0020241986,0.013756634,0.60258365,0.36037624],"study_design_scores_gemma":[0.0015045549,0.00065871584,0.1773749,0.0010668312,0.00040813783,0.00096420664,0.00051756325,0.006687972,0.001477851,0.0028348353,0.80637515,0.00012936986],"about_ca_topic_score_codex":0.79673547,"about_ca_topic_score_gemma":0.83538777,"teacher_disagreement_score":0.20326453,"about_ca_system_score_codex":0.031090371,"about_ca_system_score_gemma":0.08463567,"threshold_uncertainty_score":0.40892315},"labels":[],"label_agreement":null},{"id":"W4255805731","doi":"10.1007/bf03269472","title":"Antipsychotic polypharmacy in schizophrenia in Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polypharmacy; Antipsychotic; Quality of Life Research; Schizophrenia (object-oriented programming); Psychiatry; Medicine; Public health; Pharmacology; Nursing","score_opus":0.025288951264691797,"score_gpt":0.3464655573702587,"score_spread":0.3211766061055669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255805731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7655996,0.021777919,0.00025066177,0.17131285,0.001630769,0.00013383348,0.010467703,0.000074657946,0.028752103],"genre_scores_gemma":[0.9638152,0.013312214,0.00035681145,0.011496616,0.000592593,0.000029107177,0.0016512676,0.000027165433,0.00871899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988727,0.000085514715,0.00010162835,0.000054623775,0.00054153707,0.00034396633],"domain_scores_gemma":[0.9926617,0.00049039215,0.001102706,0.000044706845,0.0026988757,0.003001606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005352673,0.00015566692,0.00038861754,0.0016411102,0.0022544456,0.0015935124,0.00085737236,0.0014256116,0.004372544],"category_scores_gemma":[0.004070292,0.00035641177,0.00046582185,0.0038448041,0.00067997864,0.0005017412,0.00067947176,0.0017836086,0.00019913129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009251003,0.00035285624,0.7940513,0.00054131995,0.00021040028,0.0015569594,0.0015476226,0.0009621099,0.0005447234,0.0024695022,0.10913663,0.087701485],"study_design_scores_gemma":[0.00015979972,0.00007539979,0.97907835,0.00020518084,0.0000947173,0.0004199541,0.0017284749,0.0009858452,0.00011088295,0.00023705026,0.016854,0.00005037258],"about_ca_topic_score_codex":0.99605644,"about_ca_topic_score_gemma":0.9984126,"teacher_disagreement_score":0.050550412,"about_ca_system_score_codex":0.050550412,"about_ca_system_score_gemma":0.11521593,"threshold_uncertainty_score":0.36677068},"labels":[],"label_agreement":null},{"id":"W4256330601","doi":"10.1007/bf03280626","title":"Canada to respect `Cipro' patent","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Mathematics; Medicine; Public health","score_opus":0.14484623391866427,"score_gpt":0.2821749050451156,"score_spread":0.13732867112645133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256330601","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008544442,0.00488239,0.00087228185,0.40784296,0.010392809,0.00023963675,0.0009814781,0.00041592037,0.56582797],"genre_scores_gemma":[0.08436297,0.0030134604,0.001902477,0.3379004,0.001875538,0.00012212606,0.00051303086,0.00021432588,0.5700956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98386776,0.0006506072,0.0006382735,0.0010570877,0.008892602,0.00489361],"domain_scores_gemma":[0.97432613,0.0037948163,0.00090074376,0.0017728276,0.014931126,0.0042743664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006683908,0.0005795344,0.00082785153,0.0025534544,0.015785065,0.013190713,0.0029954023,0.029756123,0.035298813],"category_scores_gemma":[0.036585864,0.00095335365,0.001349843,0.002155258,0.004226581,0.0038210496,0.0038869071,0.021490145,0.004977117],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006180698,0.000052078518,0.0012411884,0.0001394938,0.00003292002,0.00050319376,0.000611277,0.00017484749,0.00054170704,0.16366154,0.8065296,0.026450373],"study_design_scores_gemma":[0.000052906486,0.000020852875,0.0023366846,0.00011888621,0.000025185582,0.00012157372,0.00037048414,0.00014114074,0.0003965308,0.0058451835,0.990524,0.000046435896],"about_ca_topic_score_codex":0.9271867,"about_ca_topic_score_gemma":0.9510774,"teacher_disagreement_score":0.07281327,"about_ca_system_score_codex":0.038707547,"about_ca_system_score_gemma":0.22198601,"threshold_uncertainty_score":0.2808442},"labels":[],"label_agreement":null},{"id":"W4256444138","doi":"10.2165/00151234-200504800-00031","title":"Expanding newborn screening warranted in Canada","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Mental Health and Psychiatry","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.038682998840174974,"score_gpt":0.3198671131999052,"score_spread":0.28118411435973023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256444138","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0700801,0.008467765,0.0005839251,0.8199663,0.0048765945,0.00019813977,0.0017648133,0.0002949669,0.09376734],"genre_scores_gemma":[0.47109342,0.013821974,0.0030894245,0.46080446,0.0035353592,0.0001735337,0.0011809595,0.00017656283,0.0461244],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99612325,0.00025222678,0.00020371747,0.0002655609,0.0010969122,0.0020582585],"domain_scores_gemma":[0.966033,0.003386584,0.0012727135,0.00030320574,0.007552708,0.021451797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00196821,0.00029725337,0.0004008466,0.0016950857,0.005214488,0.0031523036,0.0021671825,0.0063511576,0.013580317],"category_scores_gemma":[0.017370706,0.0003855805,0.0007492643,0.0017162681,0.0014613542,0.00095880096,0.001725065,0.0051590404,0.0005134976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022548932,0.0002070191,0.11280526,0.00059993414,0.00005655989,0.007602489,0.0021246087,0.001044428,0.0017128241,0.016616672,0.7296925,0.12731223],"study_design_scores_gemma":[0.00025084196,0.00025493823,0.41777593,0.003662073,0.00025246624,0.0035198892,0.009712003,0.0026408536,0.001726556,0.0059245103,0.5540921,0.00018786317],"about_ca_topic_score_codex":0.96662223,"about_ca_topic_score_gemma":0.9899288,"teacher_disagreement_score":0.06592147,"about_ca_system_score_codex":0.06592147,"about_ca_system_score_gemma":0.26444864,"threshold_uncertainty_score":0.47829598},"labels":[],"label_agreement":null},{"id":"W4256608425","doi":"10.2165/00151234-201206500-00002","title":"Canadian guidelines for AF published","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.1577735194765171,"score_gpt":0.4458158944863247,"score_spread":0.28804237500980756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256608425","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007263311,0.095261134,0.0018161532,0.19652656,0.07592784,0.0010205555,0.0614187,0.0011856108,0.5661171],"genre_scores_gemma":[0.010091546,0.12280001,0.011217047,0.05931232,0.011704785,0.0010624144,0.054923635,0.0009538346,0.7279345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912633,0.0006747062,0.00078912557,0.00031296973,0.0056513096,0.0013086494],"domain_scores_gemma":[0.97320175,0.0014759421,0.00078573875,0.00057360035,0.02114455,0.0028183104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004766537,0.0019125111,0.0017575007,0.011243713,0.004035217,0.006989424,0.003964222,0.006743383,0.12888438],"category_scores_gemma":[0.023478761,0.0009882856,0.0029444208,0.009845472,0.0017615587,0.0016375374,0.0021302933,0.0070495186,0.046096113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007073728,0.000006669844,0.000068752866,0.00010552089,0.000004516702,0.000022521912,0.000011456997,0.000026730337,0.000008333028,0.00094090746,0.9871716,0.011626077],"study_design_scores_gemma":[0.000040056144,0.0000048812153,0.00096320634,0.00079914316,0.000020499203,0.00008035251,0.000048017024,0.000031310297,0.000026907483,0.00083312026,0.99713314,0.000019310679],"about_ca_topic_score_codex":0.8912838,"about_ca_topic_score_gemma":0.92888254,"teacher_disagreement_score":0.12888438,"about_ca_system_score_codex":0.030637471,"about_ca_system_score_gemma":0.14897747,"threshold_uncertainty_score":0.43116117},"labels":[],"label_agreement":null}]}